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ABSTRACT 
 
Nitrate ingestion leads to high luminal concentrations of nitric oxide being 
generated where saliva meets gastric acid. Nitric oxide generates N-nitrosative 
stress on reacting with oxygen at neutral pH. We aimed to ascertain if luminal 
nitric oxide exerts nitrosative stress in the upper GI tract, and to assess the 
influence of acid reflux. We utilised a specialised silicone tube as an epithelial 
model, inserting it into the upper gastro-intestinal tract of humans. Healthy 
volunteers were studied with and without ingestion of 15N enriched nitrate and 
Barrett’s oesophagus patients with and without stimulation of reflux. In 
volunteers, nitrate ingestion resulted in significantly higher concentrations of N-
nitrosomorpholine in the tube sections exposed to acid. In Barrett’s patients, 
generation of N-nitrosomorpholine shifted proximally, with most nitrosative stress 
occurring within the oesophagus during reflux episodes. This chemistry may be 
harmful to patients with erosive esophagitis whose epithelium will be more 
sensitive to chemical mutagenesis. 
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SUMMARY 
 
 Adenocarcinoma of the oesophagus and gastric cardia adenocarcinoma are 
collectively known as gastro-oesophageal junction cancer. The incidence of 
neoplasia at this location has increased substantially in the last 30 years, in 
contrast to the decline in incidence of non-cardia gastric cancer. The symptoms 
associated with cancer at this site manifest late and therefore the prognosis in the 
majority of patients remains poor. Although a number of risk factors have been 
associated with this disease, none explain the reason for the remarkable increase 
in incidence observed during the final quarter of the twentieth century, which 
suggests the involvement of an environmental mutagen. 
 A possible explanation for the rising incidence of this cancer is that it 
occurs at the site where saliva of neutral pH encounters gastric acid. The 
anatomical site where those two fluids meet may be very important as their 
interaction creates reactive nitrogen species which are potentially mutagenic. The 
rise in incidence of gastro-oesophageal cancer is associated epidemiologically 
with a substantial increase in nitrogen fertiliser use 20-30 years previously. Nitrate 
consumption has increased mainly as a result of higher concentrations of nitrate in 
vegetable crops. 
 Following ingestion, nitrate is rapidly absorbed from the small intestine 
and, within 30 minutes, 25% is re-secreted into the oral cavity by the salivary 
glands. 10-90% of this nitrate is then reduced to nitrite by buccal bacteria and 
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swallowed with in saliva. Ingested nitrite has been associated with development of 
gastric tumours through formation of N-nitroso compounds in the achlorhydric 
stomach which is heavily colonised with bacteria. However in the healthy, acid-
secreting stomach, the nitrosating species formed by acidification of nitrite are 
rapidly reduced to nitric oxide where saliva meets gastric juice, which is rich in 
ascorbic acid. Very high concentrations of this lipid soluble gas are generated at 
the gastro-oesophageal junction in healthy subjects, or within the oesophagus 
when saliva meets regurgitated gastric juice in patients with gastro-oesophageal 
reflux disease. 
 This reaction can potentially lead to nitrosative stress by two separate 
mechanisms. Firstly, it has been demonstrated in humans that the luminal 
formation of nitric oxide depletes local ascorbic acid concentrations and leads to a 
high nitrite:ascorbate concentration where saliva meets acid. This creates suitable 
luminal conditions for the formation of N-nitroso compounds. Secondly, bench-
top studies have shown that luminally generated nitric oxide can form N-nitroso 
compounds within the epithelial compartment of a stomach model as a result of 
diffusion of nitric oxide through the epithelial lipid membrane. 
 The aim of this thesis was to examine if the epithelial nitrosative stress 
measured in the laboratory bench-top model could be reproduced in human 
subjects following ingestion of nitrate, and to investigate the influence of gastro-
oesophageal acid reflux on the maximal location of this stress. We utilised a 
segmented silastic tube containing phosphate buffer pH 7.4 and the secondary 
amine morpholine as an in situ epithelial model by placing it in the upper gastro-
intestinal tract of seventeen healthy volunteers and eighteen patients with Barrett’s 
oesophagus. The silicone wall of the tube possesses the same physical properties 
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as an epithelial lipid membrane, allowing passage of gases such as nitric oxide 
and oxygen but not that of hydrogen ions.  
By studying healthy volunteers with and without ingestion of 15N labelled 
nitrate we were able to demonstrate that dietary nitrate results in the generation of 
significantly higher concentrations of nitrite and N-nitrosomorpholine within our 
epithelial model, and that the proximal stomach was the site of greatest nitrosative 
stress. By studying patients with Barrett’s oesophagus following ingestion of 15N 
labelled nitrate with and without oesophageal acid reflux, we were able to 
demonstrate that during acid reflux, nitrosative stress occurs maximally within the 
oesophagus. 
This thesis has demonstrated that nitrate ingestion exerts in situ nitrosative 
stress within an epithelial model situated in the human upper gastro-intestinal tract 
and that during acid reflux this nitrosative stress occurs predominantly within the 
oesophagus. Although we have not directly measured nitrosative stress within the 
epithelial cells of the human upper GI tract, the presence of substrates for 
nitrosative stress within these cells has previously been demonstrated. This 
chemistry may be particularly harmful to patients with erosive oesophagitis whose 
epithelium will be more sensitive to chemical mutagenesis. 
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FACTORS FOR ADENOCARCINOMA AT THE  
GASTRO-OESOPHAGEAL JUNCTION  
 
 
 
 
 
 
 
 
 
 
 
 
 19
1. ADENOCARCINOMA AT THE GASTRO-OESOPHAGEAL JUNCTION 
 
1.1 Epidemiology  
In developed countries, the incidence of adenocarcinoma at the gastro-
oesophageal junction has risen markedly in the last twenty five years 1-3, and the 
increase does not appear to be explained by changes in diagnostic and reporting 
practices4-6. Gastro-oesophageal junction cancers comprise two different 
malignancies which may share a common pathogenesis: oesophageal 
adenocarcinoma and gastric cardia adenocarcinoma 1.  
Scotland has the highest reported incidence of gastro-oesophageal junction 
cancer in the world.1 Approximately 1,700 patients are diagnosed with 
oesophageal or gastric carcinoma in Scotland every year. Together, they constitute 
the 5th most common cancer, accounting for 6.5% of all new cancer diagnoses. 
Patients presenting with symptoms of these malignancies invariably have 
advanced disease, with median survival of 8.4 months from diagnosis.  Only 40% 
of patients remain alive at one year. Five year survival for both these cancers 
remains poor at 10-18% 7, and as such these malignancies account for 9.4% of 
cancer deaths. 
For most of the twentieth century, squamous carcinoma of the oesophagus 
was the most common oesophageal malignancy, comprising more than 90% of all 
oesophageal cancer in the United States of America. Over the last 30 years, the 
incidence of squamous carcinoma has remained stable, but the age adjusted 
incidence of adenocarcinoma has increased significantly, especially in white 
males 8, 9. The changing incidences of both histological types of oesophageal 
carcinoma in Scottish males and females are shown in figure 1.1 and 1.2. 
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Gastric adenocarcinoma is one of the most common forms of cancer 
worldwide, and was the leading cause of cancer deaths until the 1980s when it 
was overtaken by lung cancer 10, 11. Global incidence has declined rapidly in the 
last few decades 12, probably as a result of improved diet and living conditions, 
along with the recognition of risk factors such as Helicobacter pylori. However, in 
Western industrialised countries the incidence of adenocarcinoma of the gastric 
cardia, defined as malignancy with its epicentre between 1cm proximal and 2 cm 
distal to the gastro-oesophageal junction, has risen. The incidences of both 
anatomical subgroups of gastric cancer in Scottish males and females are 
demonstrated in figure 1.3 and figure 1.4. In 2002, 50% of gastric tumours 
occurred within the cardia, an area which represents only 5-10% of the total 
surface area of the stomach. 
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Figure 1.1: European age-adjusted standardised incidence rate for oesophageal 
carcinoma by histological type in Scottish males from 1980-2003.  
Source:  Scottish Cancer Registry, ISD Scotland. 
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Figure 1.2: European age-adjusted standardised incidence rate for oesophageal 
carcinoma by histological type in Scottish females from 1980-2003.  
Source:  Scottish Cancer Registry, ISD Scotland. 
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Figure 1.3: European age-adjusted standardised incidence rate for gastric 
carcinoma by anatomical site in Scottish males from 1980-2003.  
Source:  Scottish Cancer Registry, ISD Scotland 
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Figure 1.4: European age-adjusted standardised incidence rate for gastric 
carcinoma by anatomical site in Scottish females from 1980-2003.  
Source:  Scottish Cancer Registry, ISD Scotland 
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1.2 Risk factors  
Adenocarcinoma of the oesophagus and gastric cardia share similar risk 
factor profiles in the developed world, but for the purpose of this review each will 
first be considered separately. 
 
1.2.1 Oesophageal adenocarcinoma 
 The median age at diagnosis of oesophageal adenocarcinoma is 60 years, 
and incidence rises with increasing age. There is a striking male preponderance 
(4:1 in Scotland) which is similar in all populations studied 2, 13, 14, although the 
proportional increase in females is analogous 15. It is more common in Caucasians 
than Afro-Caribbean Americans in the USA2, 3.  
The strongest risk factor for oesophageal adenocarcinoma is the presence 
of Barrett’s oesophagus. Barrett’s oesophagus is defined by the British Society of 
Gastroenterology as an oesophagus in which any portion of the normal squamous 
lining has been replaced by a metaplastic columnar epithelium which is visible 
macroscopically16. In order to make a positive diagnosis of Barrett’s oesophagus, 
a segment of columnar mucosa of any length must be visible endoscopically 
above the oesophago-gastric junction (the confluence of the proximal limit of the 
gastric folds, the distal limit of the linear oesophageal vessels and the point of 
flaring of the stomach from the tubular oesophagus when the lumen is deflated) 
and confirmed histologically. Barrett’s oesophagus is an acquired condition 
secondary to long-standing gastro-oesophageal acid reflux, and confers a 30-60 
fold excess relative risk of oesophageal adenocarcinoma compared to the general 
population17-21. 
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Gastro-oesophageal reflux disease has been shown to be a strong and 
independent risk factor for adenocarcinoma of the oesophagus, probably acting 
via Barrett’s metaplasia. Case control studies from Sweden22 and from the USA23 
have demonstrated an association and dose-response relationship between 
frequent symptoms of acid reflux and risk of oesophageal adenocarcinoma. A 
further Swedish population based study used a cohort design to investigate the 
relationship between oesophageal reflux and adenocarcinoma. It revealed a nine-
fold increased risk of adenocarcinoma among patients with endoscopically 
verified oesophagitis24. Acid suppressive therapy and anti-reflux surgery are 
highly effective in treating erosive oesophagitis, but there is no evidence that 
either can attenuate the risk of malignancy22-27. 
A further major risk factor is obesity. Although obesity appears to increase 
the risk of gastro-oesophageal reflux disease by increasing oesophageal acid 
exposure28, there seems to be a true and dose dependent association between 
increased body mass index and risk of oesophageal adenocarcinoma which is 
independent of reflux symptoms 29-31. Among persons with a historical BMI above 
30, the relative risk has been found to be as high as 16 compared with the leanest.  
There is a strong correlation between Helicobacter pylori infection and 
non cardia gastric adenocarcinoma 32. However, there is accumulating evidence 
that H. pylori exerts a protective effect against development of adenocarcinoma of 
the oesophagus 33, 34, although the association is complex and  the mechanism 
behind this protective effect is unclear. It has been postulated that the reduction in 
intragastric acidity as a result of pan-gastritis and atrophy confers protection by 
lowering the exposure of the oesophageal epithelium to refluxing gastric acid35 
and this is supported by a recently published retrospective cohort study from 
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Sweden, which reported that patients hospitalised for duodenal ulcer had a 70% 
increased risk of oesophageal adenocarcinoma compared with population controls 
but that patients hospitalised for gastric ulcer had no change in risk36. Patients 
with duodenal ulcer are likely to have antral predominant gastritis and subsequent 
high levels of acid secretion, which could exacerbate reflux disease. Patients with 
gastric ulcer are likely to constitute a mixture of individuals with antral and with 
body predominant gastritis who have varying levels of acid production. However, 
the relationship between H pylori and oesophageal adenocarcinoma may be more 
complex than the influence of the infection on acid secretion, as a further case 
control study found that despite a three-fold reduction in risk of oesophageal 
adenocarcinoma in  patients with H. pylori, there was no association between 
gastric atrophy and oesophageal adenocarcinoma34. 
Smoking appears to exert only a moderate increase in the risk of 
oesophageal adenocarcinoma17, with two population based case control studies 
from the USA finding an increase in odds ratio two to three-fold30, 37, but a similar 
study from Sweden failing to demonstrate an association38. Although alcohol 
consumption is strongly associated with risk of squamous cancer of the 
oesophagus, it is not associated with adenocarcinoma, regardless of the type of 
alcoholic beverage consumed30, 37, 38. 
Many studies have examined the association between dietary factors and 
risk of oesophageal adenocarcinoma. However, data concerning dietary risk are 
susceptible to bias, particularly to the role of confounding by dietary variables17. 
The best established risk exposure is that of low intake of fruit and vegetables39, 40, 
possibly as a result of reduced exposure to plant based antioxidants41. 
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1.2.2 Gastric cardia adenocarcinoma 
 The gastric cardia is the most proximal region of the stomach adjoining the 
oesophagus. Its mucosa is similar to that of the gastric antrum. It is columnar in 
type, possessing mucus secreting glands but very few acid-secreting parietal cells 
or pepsin secreting chief cells. As with oesophageal adenocarcinoma, gastric 
cardia adenocarcinoma demonstrates a strong association with male gender42, 43 
but a similar proportional increase in both sexes15 in recent years. A 3:1 male 
preponderance has been observed in Scotland.  
 Symptomatic gastro-oesophageal reflux disease is associated with 
adenocarcinoma of the gastric cardia, but the association is not as strong as that 
between reflux and oesophageal adenocarcinoma. Case control22 and population 
based cohort studies24 from Sweden have demonstrated a 2-3 fold increased risk 
of gastric cardia cancer for subjects with frequent reflux symptoms.  
 As with oesophageal carcinoma, obesity is a strong and independent risk 
factor for gastric cardia cancer. A large case control study from Sweden 
demonstrated that obesity conferred an increased risk of gastric cardia cancer, 
with odds ratio of 4.3 29. Being overweight is associated with increased risk of 
both oesophageal and cardia cancer, an association which does not exist for non-
cardia gastric cancer44. 
 The relationship between Helicobacter pylori and gastric cardia 
adenocarcinoma is complex. A recent meta-analysis showed that the prevalence of 
H pylori in patients with cardia cancer was the same as in controls45. However, the 
results appear to vary with the geographical region of the study. In Eastern 
countries, there is a trend for a positive association between H pylori and cardia 
cancer. However, in Western countries, there is a strong trend for a negative 
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association. A recently published nested case control study from Norway 
examined the relationship between H. pylori status, gastric atrophy and 
adenocarcinoma from different regions within the stomach46. As expected, non 
cardia cancer showed a positive association with H. pylori infection and gastric 
atrophy. Cardia cancer was negatively associated with H. pylori, but H. pylori- 
positive cardia cancer showed a strong relationship with gastric atrophy. These 
findings indicate that there are two distinct aetiologies of cardia cancer47. In 
Eastern countries, where H. pylori infection and non-cardia gastric cancer are 
common, cardia cancer is more likely to be related to H. pylori infection and 
atrophy. However in the West, where the incidence of oesophageal 
adenocarcinoma is rising and the prevalence of H pylori infection falling, cardia 
cancer is more likely to be associated with the oesophageal adenocarcinoma 
phenotype with no atrophy and normal gastric acid secretion. The increasing 
incidence of cardia and oesophageal adenocarcinoma in Western countries 
suggests a common pathogenesis. 
 Gastric cardia cancer, like oesophageal adenocarcinoma, is positively 
associated with cigarette smoking and is not associated with alcohol 
consumption38. Some studies have indicated that cardia cancer is associated with 
low consumption of fruit and vegetables39, 40. However, interestingly, one case 
control study from Sweden noted that, although incidence was lowest in the 
patients in the highest quartile for vegetable consumption, patients with moderate 
vegetable consumption had a higher risk of cardia cancer compared with the 
lowest quartile40. 
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 1.2.3 Effect of recognised risk factors on changing epidemiology 
For any associated risk factor to be demonstrated as causal would require 
the incidence of the risk factor to be rising in a compatible epidemiological 
fashion to the incidence of the disease. None of the risk factors discussed above 
adequately explain the rapidly increasing incidence of oesophageal 
adenocarcinoma17.  
If gastro-oesophageal reflux were the main reason for the increasing 
incidence of these cancers then a similar increase in the incidence of reflux 
disease would have been expected in recent decades. The only available measure 
of the occurrence of reflux is from prevalence figures. Population based studies 
have shown no clear signs of increasing prevalence in later studies as compared 
with earlier ones48-50. If the incidence of reflux is rising, then it is likely to be due 
to a further, as yet unexplained, environmental factor. 
Although the prevalence of obesity has undoubtedly increased in the 
Western world in recent years51, the apparent sudden deflection in the incidence 
curve for adenocarcinoma, the rapidity of the increase, and the marked male 
preponderance are not consistent with obesity being the primary cause of these 
cancers3, 52. Although obesity is associated with an increased risk of many 
cancers, another interesting interpretation may be that as obese subjects consume 
more food per se, they are consuming greater quantities of an ingested mutagen 
than non obese subjects. 
Tobacco smoking and lack of fruit and vegetable intake, although 
associated, are unlikely to be causal given the prevalence of smoking is falling 
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and the ingestion of fruit and vegetables increasing in the regions of the world 
with the highest incidence of these cancers.   
An interesting observation is the association between social class and 
cancer risk. Whereas non cardia gastric cancer and squamous carcinoma of the 
oesophagus are correlated with increasing levels of deprivation, the association 
between social class and adenocarcinoma of the oesophagus and gastric cardia is 
more controversial. A case control study from Sweden found oesophageal 
adenocarcinoma to be correlated with declining socio-economic status, but the 
risk was attenuated by controlling for reflux symptoms and tobacco 
consumption53. In contrast, an analysis of population based cancer registry data 
from the West Midlands region of the UK showed that a higher proportion of 
male cases of adenocarcinoma of the oesophagus and gastric cardia were 
classified as higher social class (based on occupation) compared with other sites 
of gastric cancer, and to all sites of cancer combined13. In Scotland, the influence 
of social class was examined by using postcode as a marker. No correlation was 
found between risk of junctional adenocarcinoma and social class whereas non 
cardia gastric cancer and squamous oesophageal cancer were strongly associated 
with deprivation43. However, as this data was not adjusted for smoking (which is 
associated with deprivation in Scotland54) it is possible that the true risk is 
inversely associated with deprivation. 
The suggestion that the increase in incidence of these cancers is secondary 
to the declining prevalence of H. pylori in the Western world is interesting but 
requires further study. If this explanation is correct, it could help to explain the 
tendency towards the lower incidence of adenocarcinoma of the gastric cardia and 
oesophagus among people living in more deprived communities in Scotland. 
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The next section will discuss pathophysiological similarities between 
oesophageal adenocarcinoma and gastric cardia cancer and also describe how 
these regions may be a ripe target for an ingested environmental mutagen. 
 
1.3 Similarities between oesophageal adenocarcinoma and gastric cardia    
cancer 
Gastro-oesophageal junction cancer appears to arise from foci of intestinal 
metaplasia that develop within the distal oesophagus or proximal stomach. The 
presence of intestinal metaplasia in the distal oesophagus is described as Barrett’s 
oesophagus. As discussed above, Barrett’s oesophagus is the strongest risk factor 
for oesophageal adenocarcinoma and develops in 6-12% of patients with 
longstanding reflux symptoms 55-57.  The length of the columnar segment is 
related to the severity of the reflux disease, which is typically present for 10-12 
years before metaplasia develops. Long segment Barrett’s oesophagus (>3cm)  is 
present in 5% of patients with reflux symptoms undergoing upper GI endoscopy 
58. Interestingly, 17% of asymptomatic white male US veterans with age >50 were 
noted to have short segment Barrett’s oesophagus (<3cm) on screening endoscopy 
59.  
Intestinal metaplasia originates from tissue that has been subject to 
inflammation. In the oesophagus, it occurs as a result of acid reflux. 90% of 
intestinal metaplasia in the oesophagus is termed histologically “incomplete”, and 
defined as type II or type III on histochemical staining for mucin60-62. Intestinal 
metaplasia in this location, or Barrett’s oesophagus, confers a 10-30 fold 
increased relative risk of neoplasia63 and almost all oesophageal adenocarcinomas 
arise within tissue which has undergone a sequence of histological changes 
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initiated by inflammation – progressing from intestinal metaplasia to dysplasia 
and finally to adenocarcinoma64. 
In the distal stomach, intestinal metaplasia is associated with H. pylori 
infection. It is histologically “complete”, possessing more features found in small 
intestinal epithelium and more likely be subtype I on histochemical staining for 
mucin. In this region, intestinal metaplasia confers a 2-3 fold increased relative 
risk of neoplasia 65, much lower than in the oesophagus. Histochemical staining of 
intestinal metaplasia at the gastric cardia has revealed “incomplete” metaplasia in 
50% of cases62. This indicates that a proportion of metaplasia at this site is similar 
to the variety associated with H pylori infection found more distally within the 
stomach and a proportion is similar to the variety associated with gastro-
oesophageal reflux which is found within the oesophagus. 
 In contrast to oesophageal adenocarcinoma, cancers of the distal stomach 
comprise two distinct histological groups. The first, or “intestinal type”, develops 
via intestinal metaplasia and dysplasia in a similar fashion to oesophageal 
adenocarcinoma and contributes to approximately two thirds of non-cardia gastric 
cancers. Like oesophageal adenocarcinoma, incidence is strongly associated with 
increasing age, male sex and chronic inflammation (related to H pylori infection 
and gastric atrophy). The second histological subtype, “diffuse” gastric cancer, is 
relatively more common in females, has a weaker association with increasing age, 
and often has a strong familial tendency. Cardia cancer in the Western world is 
much more likely to be of the “intestinal” subtype46 than the diffuse subtype. This 
observation, along with its negative association with H pylori infection and gastric 
atrophy in these geographical areas, indicates that the predominant phenotype of 
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cardia cancer in Europe and North America shares a similar pathogenesis to 
oesophageal adenocarcinoma. 
It has been proposed that adenocarcinoma of the gastric cardia arises from 
two discrete and disparate aetiologies and should therefore be subdivided into two 
distinct phenotypes47. Type A comprises those cancers that are associated with H 
pylori infection, causing atrophy and intestinal metaplasia and is more prevalent 
in Eastern countries and the developing world. Type B comprises those cancers 
that are inversely associated with H. pylori infection and are aetiologically more 
similar to oesophageal adenocarcinoma, demonstrating a strong male 
preponderance and an association with reflux disease. This subtype is more 
prevalent in the Western world and its incidence is rising.  
 
1.4 Influence of acid reflux on the location of junctional cancers 
Oesophageal adenocarcinoma and a subtype of gastric cardia 
adenocarcinoma appear to be aetiologically related, with the former arising within 
intestinal metaplasia within the oesophagus (Barrett’s oesophagus) and the latter 
arising at the oesophago-gastric junction. These sites of mutagenesis correspond 
with the anatomical site where the neutral pH of the oesophageal lumen meets 
with the acidic pH of the gastric lumen. In patients with gastro-oesophageal 
reflux, this interface occurs within the oesophagus and in patients without reflux it 
occurs within the most proximal cardia region of the stomach. This is consistent 
with the observation that both oesophageal adenocarcinoma and gastric cardia 
adenocarcinoma in the Western world are significantly associated with gastro-
oesophageal reflux, although the association for gastric cardia cancer is weaker. 
Interestingly, it has been demonstrated that the most distal oesophageal mucosa is 
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frequently exposed to acidic gastric juice in healthy volunteers without reflux 
symptoms66. The proportion of cardia cancers arising from this short segment 
reflux may therefore be substantially higher than the association between these 
cancers and reflux symptoms would suggest. 
A unifying concept explaining the location of all of these adenocarcinomas 
which are increasing in incidence is that they occur at the anatomical site where 
saliva of neutral pH meets acidic gastric juice. This hypothesis is strengthened by 
the fact that in areas of the world with the highest incidence of gastric cardia 
cancer (NW Iran, Linxian region of China), the great majority of cancers occur 
high on the right side of the cardia67. This is consistent with the preferential 
passage of swallowed fluids down the lesser curve, following the ‘Magenstrasse’ 
or ‘canalis gastricus’ formed by the longitudinal mucosal folds 68.  The gastric 
cardia is an important interface zone as it has been observed that an unbuffered 
pocket of highly acidic juice resides in this region in the post-prandial state, 
escaping the buffering effect of food69. In healthy volunteers, this area of 
unbuffered acid is only 2cm long, but in patients with gastro-oesophageal reflux 
disease it is significantly more extensive and extends more proximally70. 
The observation that adenocarcinoma of the oesophagus and gastric cardia 
occur where saliva meets gastric acid suggests that the increasing incidence of 
these malignancies in Western Europe and North America is occurring as a result 
of  salivary carriage of increasing amounts of an ingested luminal mutagen. 
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CHAPTER TWO 
 
THE POTENTIAL ROLE OF DIETARY NITRATE IN THE INCREASING 
INCIDENCE OF ADENOCARCINOMA AT THE GASTRO-
OESOPHAGEAL JUNCTION 
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2.1 Dietary nitrate as a potential mutagen at the gastro-oesophageal junction 
 
2.1.1 Trends in dietary nitrate consumption 
Epidemiological observations have long indicated that ‘diet’ plays a major 
role in human carcinogenesis 71. For many years, there has been interest in the 
potential to form carcinogenic N-nitrosocompounds within the human upper 
gastro-intestinal tract. There is an epidemiological association between the 
increased incidence of adenocarcinoma at the gastro-oesophageal junction and 
increased nitrate consumption. The modern diet contains substantial quantities of 
nitrate, mainly derived from nitrogenous fertilisers 72. Nitrate is an essential plant 
nutrient and one of the main forms in which plants take up nitrogen from the soil. 
After uptake from the soil by plant roots, nitrate is reduced to the ammonium ion 
(NH4+) and then incorporated rapidly into organic compounds by the plant.  
In cooler, temperate zones (such as the United Kingdom), the growing of 
vegetables in low light intensity/high temperature glass houses leads to much 
higher nitrate concentrations than in vegetables grown in natural sunlight 73.  
Groundwater nitrate concentrations are gradually increased through leaching of 
fertiliser. After 1945, with increased intensive farming, nitrogen fertiliser use 
increased substantially. Figure 2.1 depicts nitrate fertiliser use in the UK from 
1960 to 2002. The main sources of nitrate in the human diet are green leafy 
vegetables (such as lettuce and spinach), root vegetables (such as beetroot and 
potatoes) and water.  
The established association between nitrate and infantile 
methaemoglobinaemia and the possible association between nitrate and gastric 
cancer led to governmental concern over the impact of increased population 
 38
nitrate consumption. This resulted in a series of regulations being passed from 
1970 through to 1991 aiming to reduce nitrogen fertiliser use and limit nitrate 
concentrations in food and water. The European Commission's (EC) Scientific 
Committee for Food (SCF) considered the implications for human health of 
nitrate and nitrite in food in 1990 and set an Acceptable Daily Intake (ADI) for 
the nitrate ion of 3.65 mg/kg body weight (equivalent to 219 mg/day for a 60 kg 
adult). 74 
Although nitrate fertiliser use has remained relatively stable since the early 
1980s, the 30 year gap often observed between environmental mutagen and 
disease means that we may not yet have reached the peak incidence for any 
diseases whose incidences have been influenced by increased nitrate ingestion. 
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 Figure 2.1: Nitrate fertiliser consumption in the UK 1961-2002 
Source: International Fertiliser Industry Association 
 www.fertilizer.org/ifa/statistics/IFADATA/dataline.asp
 
-
200.0
400.0
600.0
800.0
1000.0
1200.0
1400.0
1600.0
1800.0
1961/62 1966/67 1971/72 1976/77 1981/82 1986/87 1991/92 1996/97 2001/02
Year
10
00
 to
nn
es
 
 40
 2.1.2 Association between N-nitrosocompounds and carcinogenesis 
For many years, luminal nitrite has been recognised as a potential 
carcinogen. This is due to its ability to be converted to carcinogenic N-
nitrosocompounds under conditions present in the human upper GI tract. Interest 
in N-nitrosocompounds was limited to the chemical laboratory and to industrial 
applications, where secondary amines were used as a solvent in the rubber 
industry until, during investigation of the hepatotoxicity suffered by workers in 
the rubber industry75, it was noticed that N-nitrosodimethylamine was a potent 
carcinogen in rodents76. Further studies revealed that while a wide range of N-
nitrosocompounds were carcinogenic, the target organ varied depending on the 
type of N-nitrosamine and species of animal77. The discovery that this group of 
chemicals readily promoted carcinogenesis led many investigators to utilise N-
nitrosocompounds for the induction of tumours in animals in studies of aetiology, 
rate of growth and treatment of neoplasia.  
N-nitrosocompounds are potent inducers of oesophageal and gastric cancer 
in laboratory animals 78. The effect of reflux on carcinogenesis associated with 
preformed N-nitrosocompounds was examined by Atwood and colleagues, who 
performed oesophago-gastroplasty in 20 rats and oesophago-duodenal 
anastomosis in a further 60 before exposing each group to N-nitrosamines79. Rats 
with duodeno-oesophageal reflux had an increased rate of oesophageal carcinoma. 
Furthermore, the type of refluxate altered the histological type of cancer, with 
duodenal reflux promoting development of adenocarcinomas as compared with 
squamous carcinomas in rats with the oesophagogastroplasty. These studies show 
that exposing the rat oesophagus to preformed N-nitrosamines and refluxed 
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duodenal contents promotes development of adenocarcinoma. This suggests that a 
similar mode of carcinogenesis may occur in humans with reflux of duodenal 
contents into the oesophagus. Bile and other duodenal juices have been detected 
in the oesophagus of patients with severe reflux disease and Barrett’s oesophagus. 
Although ingestion of preformed N-nitroso compounds is rare, these compounds 
can be generated by reaction of secondary nitrosatable amino compounds with 
nitrite under the correct chemical conditions. The main source of nitrite in the 
human upper gastrointestinal tract is swallowed saliva, and its high nitrite content 
is derived from dietary nitrate. 
Humans can be exposed to preformed N-nitrosocompounds and to N-
nitrosocompounds produced in vivo. This in vivo formation can occur by acid 
catalysed and bacterial nitrosation in the stomach and via nitric oxide formation 
during inflammation 80. Recently, a novel mechanism for the formation of N-
nitrosocompounds via intra-luminal nitric oxide has been described, which may 
be of importance in the pathogenesis of gastro-oesophageal junction cancers 81. 
N-nitrosocompounds have the potential to induce mutagenesis by their 
ability to alkylate human DNA. Tobacco specific N-nitrosocompounds have been 
implicated in the pathogenesis of cancers of the bronchus, oral mucosa and 
squamous oesophagus in tobacco users. Oral cancer is associated with N-
nitrosamines in chewing tobacco82, 83 and  betel quids. The high incidence of 
bladder carcinoma in rubber factor workers has been associated with the high 
concentrations of volatile N-nitrosocompounds in the air of rubber factories 84. 
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2.1.3 Mechanisms of in-vivo Nitrosation 
The first clear demonstration that humans can form N-nitrosocompounds 
in vivo was made in 1981, when it was shown that human ingestion of nitrate and 
L-proline resulted in measurement of significant concentrations of N-
nitrosoproline in urine 85. N-nitrosoproline was formed by gastric nitrosation of L-
proline, with subsequent absorption and excretion in the urine. Formation of this 
non-carcinogenic N-nitrosamine was inhibited by ingestion of the anti-oxidants 
ascorbic acid and alpha-tocopherol. 
Nitrite is an essential substrate for in vivo nitrosation. The main route of 
entry to the body is via the stomach, making this organ a prime candidate for N-
nitroso compound mediated mutagenesis. 80% of nitrite entering the normal, acid 
producing stomach arises from the reduction of ingested or endogenous nitrate via 
the entero-salivary circulation. After dietary nitrate is absorbed, about 25% is 
actively secreted into the mouth by the salivary glands 86. Bacteria on the dorsum 
of the tongue then convert 10-90% of this nitrate to nitrite 87, 88, producing high 
concentrations of nitrite in saliva. The remaining 20% of gastric nitrite arises from 
ingested nitrite in nitrite-preserved meat and fish and other foods 89. 
Formation of N-nitrosocompounds may occur via acid nitrosation, 
bacterial nitrosation or via nitric oxide. The former two mechanisms are observed 
to occur following ingestion of exogenous nitrate and nitrite. Until recently, nitric 
oxide-mediated nitrosation was perceived to occur only from endogenous 
substrate in the context of inflammation.  
Acidification of nitrite leads to the formation of nitrous acid, a precursor to 
the formation of nitrosating species. Nitrous acid dimerizes with loss of water to 
form N2O3 , and can be protonated to form H2NO2+. Because of the acidification 
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step, these reactions are most likely to take place in the human stomach. A further 
nitrosating species in this organ is nitrosothiocyanate (NOSCN), formed by 
reaction of acidified nitrite with thiocyanate, which is present in high 
concentrations in saliva 90, 91 and increased by smoking. 
Bacterial nitrosation proceeds at neutral pH and is most likely to take place 
within the achlorhydric stomach, as can occur in Helicobacter pylori mediated 
gastric atrophy. Ascorbic acid, an aqueous anti-oxidant, is actively secreted into 
gastric juice by healthy gastric mucosa and inhibits the potential for both acid and 
bacterially mediated nitrosation 92. However, ascorbic acid levels are reduced in 
hypochlorhydric gastric juice 93, therefore increasing potential for nitrosation. 
Acid and bacterial 94 nitrosation  have been implicated in the pathogenesis of 
intestinal type gastric carcinoma, which manifests in patients with 
hypochlorhydria, low ascorbic acid levels and chronic inflammation with 
intestinal metaplasia. 
 
2.1.4 Nitric oxide-mediated nitrosation in inflammation 
Endogenous nitric oxide (NO) is produced by the oxidation of an omega 
nitrogen of the amino acid arginine by nitric oxide synthase enzymes. This NO 
serves as a vasodilator and as a neurotransmitter but the concentrations produced 
for these functions are far less than those formed during the oxidative burst 
produced by macrophages and neutrophils during inflammation. NO reacts with 
dissolved oxygen to form nitrosating species. These then react with water at 
neutral pH to produce nitrite and with secondary amines and amides to form N-
nitrosocompounds. These reactions occur near the site of NO production. 
 44
Chronic inflammation is associated with the pathogenesis of many 
malignancies, including colorectal carcinoma in ulcerative colitis, bladder 
carcinoma in bilharzia (schistosomiasis), hepatocellular carcinoma in chronic viral 
hepatitis and gastric carcinoma in chronic H pylori infection. These associations 
may be partially due to NO formation 95. There are at least three mechanisms by 
which intracellular elevated NO could exert genotoxic affects after reacting with 
O2. These include direct deamination of DNA bases, oxidation of DNA after 
formation of peroxynitrite and/or hydroxyl radicals and through generation of 
carcinogenic N-nitroso compounds. Synthesis of N-nitrosocompounds by 
activated human neutrophils via inducible nitric oxide synthesis has been 
demonstrated96. One or more of these mechanisms could, theoretically, explain 
why chronic infection increases the risk of certain cancers 97 
 
2.1.5 Nitric oxide-mediated nitrosation at the gastro-oesophageal junction 
In recent years, it has been observed that the highest concentrations of 
nitric oxide occurring in the body are not the result of enzymatic synthesis but 
caused by chemical formation within the lumen of the stomach 98, 99. This arises 
from the entero-salivary circulation of dietary nitrate. As described above, 
bacteria on the dorsum of the tongue reduce the nitrate actively secreted into the 
oral cavity to nitrite. This nitrite is then swallowed. On meeting gastric acid, 
nitrous acid is formed, which dissociates to form the nitrosating species.  
Ingestion of a nitrate containing meal leads to elevated concentrations of 
nitric oxide within the gastric lumen 100-102, accompanied by a fall in gastric 
ascorbic acid concentration 103.  This can be explained by reduction of nitrosating 
species to nitric oxide by ascorbic acid, with its concurrent oxidation. In vitro 
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studies using a chemical stomach model have confirmed this mechanism 104, and 
have revealed that the reaction between the nitrite and ascorbic acid is extremely 
rapid, causing most of the nitrite to be converted to nitric oxide within a few 
seconds. This suggested that the production of nitric oxide from dietary nitrite 
would be most evident at the gastro-oesophageal junction, where saliva containing 
nitrite and gastric juice first meet. 
This hypothesis was confirmed in 2002, when Iijima and colleagues 105 
measured luminal pH and dissolved nitric oxide concentrations at 1cm intervals 
throughout the length of the stomach and distal oesophagus in 15 healthy human 
volunteers with and without ingestion of 2mmol potassium nitrate. Peak nitric 
oxide concentrations occurred within 1cm distal to the pH step up point.  In 75% 
of subjects mean nitric oxide concentrations at the gastric cardia were 
significantly greater than at all other sites. A combined pH and nitric oxide tracing 
from one individual is shown in figure 2.2.  
In patients with gastro-oesophageal reflux disease, the anatomical location 
where saliva meets gastric acid is different to normal subjects. In these 
individuals, acid and nitrite-rich saliva meet within the distal oesophagus and 
intra-luminal production of nitric oxide has been shown to occur at that site 106. 
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Figure 2.2: Tracing obtained in a single individual while a pH/nitric oxide sensor 
is withdrawn from the distal stomach into the oesophagus at 1cm increments 
every 2 minutes. A rise in nitric oxide concentration is seen on reaching the 
gastro-oesophageal pH step-up. 
 
From :  Iijima K, Henry E, Moriya A, Wirz A, Kelman AW, McColl KE.  
Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the 
gastro-oesophageal junction. Gastroenterology 2002;122:1248-57. 
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2.1.6 Epidemiological associations between ingestion of nitrate and nitrate-
rich foods and gastro-oesophageal cancer 
 
Although the temporal association between increased nitrate consumption 
and the rising incidence of adenocarcinoma of the gastro-oesophageal junction is 
intriguing, there is currently no hard epidemiological evidence to substantiate this. 
Despite the observation that N-nitrosocompounds induce tumours in more than 40 
animal species107, there is no conclusive evidence that they are carcinogenic to 
humans. Two N-nitrosamines (N-nitrosodimethylamine and N-
nitrosodiethylamine) are classified as probably carcinogenic by the International 
Agency for Research on Cancer108. Several studies have analysed the association 
between nitrates, nitrites and preformed N-nitrosocompound intake. One recent 
review found that available evidence supported a positive association between 
nitrite and nitrosamine intake and gastric cancer, but not conclusively so108. 
 There are few epidemiological studies examining the association between 
nitrate intake and upper gastrointestinal cancer. Even fewer have controlled for 
the influence of Helicobacter pylori or have analysed oesophageal squamous 
carcinoma and adenocarcinoma separately. In the Shangdong Peninsula in north-
eastern China, very high drinking water nitrate concentrations (from local wells) 
were correlated with the incidences of pre-malignant gastric lesions and gastric 
cancer109. In the Western world, where the principle source of ingested nitrate is 
from vegetables110 and drinking water nitrate content is lower, no such association 
has been demonstrated between drinking water nitrate and upper gastrointestinal 
cancer incidence111-114. A large epidemiological study conducted across many 
countries used 24 hour urinary nitrate levels as a surrogate for nitrate intake and 
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demonstrated a strong correlation between urinary nitrate levels and mortality 
from gastric cancer115. However, it was suggested that salt intake was the rate 
limiting factor for stomach cancer mortality and that nitrate appeared to be only 
important with higher salt intake levels.  
 The association between nitrate intake and gastric cancer has been 
investigated by cohort studies from Western Europe116, 117. Taken together, these 
studies indicate a trend towards a protective effect with increasing nitrate intake 
and this appears to be attributable to nitrate intake from food rather than from 
drinking water. These findings are likely to reflect the protective effect of 
vegetable consumption against risk of non-cardia gastric cancer risk. The different 
subgroups of gastric cancer have not been studied separately and the influence of 
nitrate consumption on risk of oesophageal adenocarcinoma has not been 
investigated. 
 A further conceptual problem in associating the increasing incidence of 
junctional adenocarcinoma with nitrate consumption in the Western world is the 
fact that most nitrate ingested comes from dietary sources110 and the greatest 
dietary source is vegetables, which are generally considered to have a protective 
effect against the occurrence of cancers of the aero-digestive tract118. However, 
recent epidemiological studies have cast doubt on this hypothesis. A 
comprehensive meta-analysis from 2003119 included 1 cohort study (from China) 
and 12 case control studies which examined the association between fruit and 
vegetable intake and oesophageal carcinoma. The different histological subgroups 
(squamous and adenocarcinoma) were not differentiated. The case control studies 
from Europe and the USA indicated a significant protective effect for fruit but not 
for vegetables. 6 cohort studies and 14 case control studies were identified which 
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examined association between fruit and vegetable intake and gastric cancer 
incidence. The different regions of cancer occurrence (cardia and non-cardia) 
were not differentiated and there appeared to be a significant protective effect 
from higher fruit and vegetable intake, which was stronger for case control than 
for cohort studies. 
 Subsequent to the above meta-analysis, two large cohort studies have been 
published which have examined the association between fruit and vegetable intake 
and cancers of the oesophagus and stomach. The EPIC-EUROGAST study120 
collected dietary information from over 500,000 subjects in 10 European 
countries and data on oesophageal and gastric cancer incidence has now been 
reported after an average of 6.5 years follow up. This study has concentrated on 
oesophageal adenocarcinoma and has differentiated gastric cancer according to 
histological type (intestinal or diffuse) and region (cardia and non-cardia).  
Although there did appear to be a non-significant protective effect against 
oesophageal adenocarcinoma in those with the highest vegetable intake, overall 
there was no evidence of a significant association between vegetable intake and 
risk of gastric or oesophageal adenocarcinoma. This lack of association may be 
due to the relatively short period of follow up and to the small number of cancers 
identified in the follow up period (330 gastric cancers and 65 oesophageal 
cancers). The NIH-AARP Diet and Health study121 examined dietary influences 
on oesophageal carcinoma in the USA following a similar design and provides the 
best prospective data on association currently. The subjects recruited were 
generally older (> 50 years at recruitment) and were followed up for a median of 5 
years. A greater number of oesophageal cancers were identified in this study than 
in the European cohort (213 adenocarcinomas). Higher fruit intake, but not 
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vegetable intake, conferred a significant protective effect against development of 
oesophageal squamous cancer. No protective effect was seen for vegetables 
against development of either histological subgroup of cancer. 
 In summary, although there currently is a lack of epidemiological evidence 
suggesting that nitrate intake is associated with increased risk of adenocarcinoma 
of the gastro-oesophageal junction, recent prospective studies cast doubt on the 
previously held view that higher vegetable intake protects against development of 
these cancers in Western populations. These observations may be prejudiced by 
under-powering due to the relatively short follow up periods in the large cohort 
studies, resulting in small numbers of the cancers of interest being reported to 
date. However, as the published data currently stands, the potential influence of 
increasing nitrate consumption on the rising incidence of these tumours cannot 
presently be dismissed.  
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2.2.   Detailed studies of nitrosation at the gastro-oesophageal junction 
 
2.2.1 Bench-top model of luminal chemistry at gastro-oesophageal junction 
Given that the highest concentrations of nitric oxide measured anywhere in the 
human body are produced chemically where saliva meets gastric acid, it seems 
likely that this anatomical location is a target for nitric oxide-mediated nitrosative 
stress.  
To investigate this further, our group developed a bench-top model re-
creating the chemical conditions present at the human gastro-oesophageal 
junction81.  A transparent plastic cylinder was filled with 20ml of hydrochloric 
acid pH 1.5 to represent the gastric lumen. Vertical fenestrations were cut into the 
walls of the cylinder and silastic tubing with internal diameter of 500 um and wall 
thickness 250um was wound around the cylinder in a single layer, completely 
occluding the fenestrations (figure 2.3). The silastic tube contained phosphate 
buffer pH 7.4 to represent the epithelial compartment.  The chemical 
characteristics of silastic closely resemble those of lipid membranes, allowing the 
passage of gases such as nitric oxide and oxygen, but not that of hydrogen ions 122-
124.  
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Figure 2.3:  Diagrammatical cross-section of the bench-top model used to study 
nitrosative chemistry at the oesophago-gastric junction. 
 
From:  Iijima K, Grant J, McElroy K, Fyfe V, Preston T, McColl KE. 
 
Novel mechanism of nitrosative stress from dietary nitrate with relevance 
to gastro-oesophageal junction cancers. Carcinogenesis 2003;24:1951-60. 
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The exterior surface of the silastic tube was exposed to the chemistry occurring in 
the lumen of the gastro-esophageal junction when saliva meets acidic gastric 
juice, and this we refer to as the luminal compartment. The secondary amine, 
morpholine, was added to both the luminal and epithelial compartments. When 
the luminal compartment contained nitrite and hydrochloric acid, there was 
formation of N-nitrosomorpholine only in the luminal compartment. The further 
addition of ascorbic acid to the luminal compartment transformed the chemistry in 
both compartments - preventing N-nitrosomorpholine generation in the luminal 
compartment, generating high concentrations of nitric oxide in the luminal 
compartment and high concentrations of N-nitrosomorpholine in the adjacent 
epithelial compartment. The findings are explained by the nitric oxide generated 
by the reaction between acidified nitrite and ascorbic acid diffusing into the 
epithelial compartment and within it reacting with oxygen to form N2O3, which 
was nitrosating the morpholine. Nitrite was formed within the epithelial 
compartment by two mechanisms. The first and major mechanism is via nitric 
oxide. The N2O3, formed by nitric oxide within the membrane reacts with water to 
form nitrite (N2O3 + H2O --> 2 NO2- + 2 H+). The second mechanism by which 
nitrite may accumulate within the tube is due to nitrous acid diffusing through the 
wall of the tube (Figure 7).  The addition of ascorbic acid or glutathione to the 
epithelial compartment could only reduce the generation of N-nitrosomorpholine 
by a maximum of 40%.  The silastic tube filled with phosphate buffer thus 
provides a means of measuring in-situ N-nitrosation arising from luminally 
generated nitric oxide and within a chemical environment resembling epithelial 
cells. 
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Figure 2.4: Chemical reactions occurring when nitrite enters acidic gastric juice. Nitrite is 
converted to nitrous acid and nitrosating species (N2O3, NO+ and NOSCN). In the 
absence of ascorbic acid, these can react with nitrosatable species to form N-
nitrosocompounds in the luminal compartment. Ascorbic acid in the gastric juice prevents 
this luminal nitrosation by converting the nitrosating species to nitric oxide. However, 
nitric oxide can diffuse into the epithelial compartment, reacting with oxygen to form the 
nitrosating species N2O3 which exerts nitrosative stress within the epithelial compartment.  
Nitrite is formed in the epithelial compartment predominantly by reaction of N2O3 with 
water, but also by diffusion of nitrous acid (NO2). 
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2.2.2 Two potential mechanisms for nitrosative stress at the gastro-
oesophageal junction 
Delivery of nitrite-rich saliva to the oesophago-gastric junction can potentially 
lead to mutagenesis at this site by two distinct mechanisms: via acid nitrosation in 
the lumen and via nitric oxide-mediated nitrosation in the epithelium 
 
2.2.2.1 Acid Nitrosation in the Lumen 
A validated technique using microdialysis probes125 was used to measure 
chemicals involved in nitrosation within the oesophagus, cardia and proximal and 
distal stomach of 17 healthy volunteers before and after administration of 
2mmoles nitrate intra-gastrically126. Before nitrate administration, the lowest 
concentrations of ascorbic acid were detected at the gastric cardia. The reason for 
this is unclear. However, ascorbic present within fasting gastric juice is believed 
to be actively secreted by the gastric mucosa93, 127 and, although the cells 
responsible for secreting ascorbic acid are unknown, biopsies from different 
regions of the stomach have shown that mucosal levels of vitamin C are highest in 
the antrum128.  
Following nitrate administration, luminal nitrite concentrations increased 
significantly within the cardia but not within the proximal and distal stomach. The 
lowest ascorbic acid concentrations were again measured at the cardia. This 
region had the lowest median ascorbate: nitrite ratio before and after 
administration of nitrate and the ratio fell after nitrate administration. Therefore 
the most favourable conditions for luminal acid nitrosation were present at the 
gastric cardia.  
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Gastro-oesophageal reflux was stimulated in ten patients with Barrett’s 
oesophagus, who were then studied in identical fashion106. During acid reflux, the 
Barrett’s segment of the oesophagus had the lowest ascorbate:nitrite ratio and 
therefore was the region with greatest potential for acid mediated nitrosation 
within the lumen.  
It seems likely that, in the absence of reflux, the proximal cardia region of the 
stomach possesses the lowest ascorbic acid concentrations because it is the region 
furthest from the site of ascorbic acid secretion. When nitrite present in swallowed 
saliva meets gastric acid, the nitrite concentration falls rapidly due to reduction of 
nitrosating species by ascorbic acid to nitric oxide. The cardia therefore has the 
lowest ascorbate:nitrite ratio in the upper gastrointestinal tract because local 
ascorbic acid is consumed and some nitrite remains. During reflux, the nitrite 
meets gastric acid more proximally, within the distal oesophagus, and this region 
then becomes the site with lowest ascorbate:nitrite ratio. With ingestion of 
increasing amounts of nitrate, an even lower ascorbate:nitrite ratio is anticipated 
as higher concentrations of luminal nitrite will remain once the local ascorbic acid 
has been exhausted.  
 
2.2.2.2 Nitric Oxide-Mediated Nitrosation within the Epithelium 
In the bench-top model described by Iijima81, generation of nitric oxide can 
lead to nitrosative stress occurring within the epithelium as a result of the nitric 
oxide diffusing into the epithelial lipid membrane and forming nitrosating species 
at this site. Epithelial cells contain many compounds (secondary amines, 
polyamines, amino acids, peptides and amides) which can be N-nitrosated to 
mutagenic products129-134.  
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The aim of this thesis is to translate the bench-top studies of nitric oxide 
nitrosative stress to human subjects, by examining the potential for nitrate to 
generate  N-nitroso compounds in the epithelium of the human upper GI tract. 
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CHAPTER 3 
 
PLAN OF INVESTIGATION 
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3.1 Hypothesis 
 
Our in vitro and in vivo studies have generated the hypothesis that: 
 
“The high luminal concentration of nitric oxide generated at the anatomical 
site where nitrite-laden saliva first encounters acidic gastric juice is exerting 
nitrosative stress on the adjacent epithelium and thereby contributing to the 
high incidence of mutagenesis at this location”.  
 
This hypothesis is consistent with the epidemiological characteristics of 
cancer at the gastro-oesophageal junction. 
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3.2 Aims of the thesis 
 
To test our hypothesis, we aimed to determine whether nitric oxide generated 
within the human upper gastrointestinal tract from dietary nitrate can lead to 
in-situ generation of nitrosating species and N-nitroso compounds within the 
adjacent epithelial compartment. 
 
The main research questions to be addressed were: 
 
(1) Does the luminal generation of nitric oxide from dietary nitrate exert 
nitrosative stress and lead to in-situ generation of N-nitrosocompounds 
within the adjacent epithelial compartment? 
 
(2) Does the anatomical location of maximal nitrate-induced epithelial 
nitrosative stress correspond to the locations of high cancer incidence i.e. 
at the gastric cardia in subjects without acid reflux and within the distal 
oesophagus in patients with acid reflux?  
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3.3 Description of proposed investigative method 
 
We proposed to employ a similar epithelial model as in our in vitro studies 
81. This epithelial model was to be inserted in the upper gastro-intestinal tract of 
human subjects, and used to ascertain if nitric oxide derived from ingested nitrate 
resulted in the in situ generation of nitrite and N-nitrosocompounds. 
The epithelial model was to consist of a silastic tube containing the 
secondary amine morpholine, buffered at pH 7.4. As described above, the 
chemical characteristics of silastic are similar to that of the epithelial lipid 
membrane, allowing passage of small, non-ionic lipid soluble molecules such as 
nitric oxide (NO) and oxygen (O2), but not that of hydrogen ions (H+). To provide 
information on localised chemistry in the human upper GI tract, the tube required 
to be partitioned into short segments. In order that we were able to confirm the 
location of the tube in the upper gastro-intestinal tract, it required to be attached to 
a multi-channel pH catheter. 
We aimed to recruit 20 Helicobacter pylori-negative healthy volunteers 
and 20 Helicobacter pylori-negative patients with severe gastro-oesophageal 
reflux and associated Barrett’s oesophagus. The size of the study was based upon 
results of earlier studies of luminal nitrosative stress performed in our unit, in 
which nitric oxide production was found to be maximal at the gastro-oesophageal 
junction using 12 patients at p=0.02.  All subjects would attend for investigation 
on two separate study days. On each visit, the tube was to be inserted into the 
stomach by the nasal or oral route and remain in-situ for two hours after 
administration of a study drink. Blood and saliva samples were to be collected at 
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regular intervals for measurement of serum nitrate and salivary nitrite 
concentrations. 
The healthy volunteers were to ingest water containing 2 mmoles of 15N 
enriched potassium nitrate (50% of the Acceptable Daily Intake for a 70kg 
human) on one day and water only on the other visit as a control. The patients 
with Barrett’s oesophagus were to ingest water containing 2 mmoles of 15N 
enriched potassium nitrate on each study day. On one day, we attempted to 
stimulate acid reflux in the patients with Barrett’s oesophagus.  
The purpose of this study was to determine (a) whether N-
nitrosomorpholine is generated within the tube in situ; (b) whether the 
concentration N-nitrosomorpholine is higher after nitrate; (c) whether there is 15N 
enrichment of the N-nitrosomorpholine further confirming that it originated from 
the ingested nitrate; (d) whether the concentrations of N-nitrosomorpholine and 
nitrite generated within the tube are maximal at the gastric cardia in patients 
without reflux and within the oesophagus in those with reflux.  
Before commencing our studies in humans, we required to perform a 
number of laboratory experiments to confirm that our apparatus was suitable and 
our experimental and analytical methods were correct. 
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   CHAPTER 4  
 
DESIGN OF EXPERIMENTAL METHOD FOR STUDIES 
OF NITROSATIVE CHEMISTRY IN HUMAN SUBJECTS 
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4.1 Silastic Tube 
 
4.1.1 Appropriate dimensions of silastic tube 
We required to adapt the silastic tube which had been employed in our 
previously published in vitro studies81 for use in human subjects. Before, a long 
tube with narrow internal diameter (0.5mm) had been used, containing a total 
fluid volume of 250ul. As we planned to investigate localised in situ chemical 
change in our human studies, we required to partition the tube into multiple 
sections of equal length and of adequate volume to permit analysis of nitrite and 
N-nitrosomorpholine concentration. To permit analyses of the silastic tube 
contents, a minimum segmental volume of 50ul was required. This provided 10ul 
of fluid for measurement of nitrite concentration and 40ul of fluid for analysis of 
N-nitrosomorpholine concentration. We therefore chose to employ silastic tubing 
(Altec Corporation, Cornwall, UK) with internal diameter of 2.5mm and wall 
thickness 0.5mm. When partitioned into sections of 15mm length, each section 
contained a maximum volume of 74ul of fluid, which was adequate for our 
analyses. 
 
4.1.2 Compartmentalisation of silastic tube 
To study localised chemical change in the human upper gastro-intestinal 
tract, it was important that our tube was divided into multiple compartments of 
equal size and good integrity. Initially it was realised that in order to obtain 
compartments with no leakage through to other neighbouring compartments we 
had to twist the tube along its longitudinal axis at the appropriate length, creating 
a compressed area of tube of 3-5mm in length.  Suture material was then tied at 
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proximal margin of the compressed section, wrapped around the segment ten 
times and tied again at the distal margin. Several different materials were tried to 
tie a suitable knot.  Of those tried, 4-0 vicryl suture (Ethicon Corporation, 
Somerville, New Jersey, USA) was the most suitable as it provided required 
strength while remaining soft enough to avoid cutting through the silicone wall. 
Inter-compartmental integrity was tested both subjectively and objectively: 
subjectively, by noting that there was no contribution to aspirated volume from 
adjacent segments when each was drained using a glass syringe; and objectively, 
by partitioning fluid of varying pH between different sections and observing that 
pH was maintained after being left for a period of twelve hours. 
  
4.2 Design of experimental method for N-nitrosomorpholine sample 
preparation 
 
4.2.1 Choice of substrate secondary amine 
Morpholine is a heterocyclic secondary amine with the chemical formula 
C4H9NO. It is a weak base with pKa of 8.3. It reacts with nitrosating species to 
form N-nitrosomorpholine, a volatile N-nitrosamine which can be detected by gas-
chromatography and mass spectrometry. Morpholine is a suitable substrate to 
assess nitrosation in our in-situ studies as neither it nor N-nitrosomorpholine occur 
naturally within biological systems. Therefore, any N-nitrosomorpholine 
measured in our analysis is derived from nitrosation of the provided substrate and 
the amount measured is therefore not contributed to via contamination by 
substrate or product. 
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4.2.2 Choice of internal standard 
Our silastic tube sections contained morpholine dissolved in aqueous 
solution and buffered at pH 7.4 using 0.02M phosphate buffered saline. In order to 
analyse N-nitrosomorpholine formed within the silastic tube solution we had to 
transfer it from the aqueous to the organic solvent phase. Analysis also required 
addition of an internal standard. N-nitrosodibutylamine was chosen as an internal 
standard. It is an aliphatic N-nitrosamine with a high boiling point and a similar 
polarity to N-nitrosomorpholine, and therefore should partition between the 
aqueous and organic solvent phases in similar proportions to N-
nitrosomorpholine.  
 
4.2.3 Choice of extraction solvent mix 
We measured N-nitrosamine concentrations by gas chromatography: 
tandem mass spectrometry using the Finnigan PolarisQ GC/MSn Bench top Ion 
Trap Mass Spectrometer (Thermo Electron Corporation, Austin, Texas, USA). 
The analytical method required N-nitrosamines to be dissolved in the organic 
solvent dichloromethane. Both N-nitrosomorpholine and N-nitrosodibutylamine 
preferentially move into the organic solvent phase, and this can be enhanced by 
increasing the ionic content of the aqueous phase by adding a concentrated ionic 
solution such as 2M sodium chloride. Dichloromethane (CH2Cl2) is an organic 
solvent with density higher than water (1.33g/cm3 ), and therefore forms a layer 
below the aqueous layer on mixing. As we were working with small volumes, 
removal of the organic solvent layer would be simpler if it formed a layer above 
the aqueous phase. To facilitate this, we mixed the dichloromethane (DCM) with 
diethyl ether (C4H10O) in a ratio of 45:55. Diethyl ether (DEE) is a solvent with 
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low density (0.71 g/cm3) which is infinitely miscible with DCM. Mixing in the 
above proportions creates an organic solvent phase which is less dense than the 
aqueous phase and therefore lies above it, making removal easier. Following its 
removal, the organic solvent layer can be concentrated by blowing down in a 
gentle stream of nitrogen gas. 
 
4.2.4 Artefact formation during sample preparation 
If the sample or analytical agents contain nitrite then formation of N-
nitroso compounds may occur by artefact during the analytical process. This 
should only occur in aqueous solutions below pH 7, as the nitrite ion is ineffective 
as a nitrosating agent in the absence of catalysts such as mineral acids 135. In 
acidic aqueous solutions,  sulphamic acid 136, 137 is often employed to remove 
nitrite by reacting with it to produce nitrogen gas. Both nitrite and N-
nitrosomorpholine are likely to be formed within our silastic tube sections by 
reaction of nitrosating species generated via nitric oxide with water and 
morpholine respectively. Providing the pH remains 7.4 then nitrosation should not 
occur once the tube is removed from a luminal environment containing large 
amounts of nitric oxide, as the nitrite ion is ineffective as a nitrosating agent in the 
absence of mineral acids 135. Sulphamic acid had been added in the analyte 
preparation in our previously published work 81, but we had been measuring N-
nitrosamines in acid solution as well as pH neutral solution in that circumstance. 
Under less acidic solutions sulphamic acid is very much less effective135, and 
there were concerns that its presence may result in hydrolysis of N-nitrosamines at 
neutral pH. Additionally, it has been reported that at pH 4.0 sulphamic acid can 
actually enhance N-nitrosation 138.   
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We suspected that artefactual N-nitrosation of morpholine would not occur 
by exposure of morpholine to nitrite at pH 7.4 and that using sulphamic acid in the 
processing of our samples was therefore unnecessary and possibly deleterious. We 
required to perform a few experiments to investigate this. 
 
4.2.4.1 Artefact formation from exposure of morpholine to nitrite at pH 7.4 
We designed an experiment to confirm whether further nitrosation 
occurred when morpholine was exposed to nitrite at neutral pH in the absence of 
exposure of the surface of the tube to nitric oxide.  50ml of 0.02M phosphate 
buffered saline containing 25mM morpholine (pH 7.4) was added to a glass 
beaker. Earlier laboratory studies carried out by my colleague Dr Stuart Paterson 
had ascertained that a morpholine concentration of 25mM was optimal for the 
assessment of nitrosation. 
 Sodium nitrite was then added to give a final nitrite concentration of 
100uM. The solution was then left to stand at room temperature for 30 minutes, 
representing the time delay from removal of the silastic tube from the human 
subject to its transfer to the laboratory for analysis. After 30 minutes, five 40ul 
aliquots were processed and analysed for N-nitrosomorpholine. As a control, five 
40ul aliquots of the beaker solution were removed prior to addition of nitrite. No 
N-nitrosomorpholine was detected in any of the 5 samples or 5 controls, 
confirming that further N-nitrosation does not occur when morpholine is exposed 
to nitrite at pH 7.4. This finding confirmed that we did not need to remove the 
nitrite from the pH 7.4 solution when preparing for N-nitrosamine analysis. 
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4.2.4.2 Evaluation of efficiency of the extraction process with and without   
sulphamic acid 
We planned to assess the efficiency of our N-nitrosamine extraction 
process and the effect of sulphamic acid on this. We designed an experiment to 
analyse the correlation between expected and measured N-nitrosomorpholine 
concentrations following extraction in a series of aqueous N-nitrosomorpholine 
solutions of varying strength. 
Eight solutions of N-nitrosomorpholine were prepared in 0.02M phosphate 
buffered saline. Concentrations were 0 uM, 1.7uM, 8.6uM, 17.2uM, 43 uM, 86 
uM, 129 uM and 172 uM. 40ul aliquots of each of these solutions was added to a 
polypropylene vial along with 10ul N-nitrosodibutylamine (internal standard) and 
50ul of either 5% sulphamic acid solution in 6M sodium chloride (as previously 
used 81) or 2M sodium chloride. The nitrosamines were then extracted into 
organic solvent using a 45:55 mix of DCM: DEE. The extraction procedure was 
repeated to optimise recovery. N-nitrosomorpholine concentration was then 
measured by GCMS/MS. 
The expected and measured concentrations of N-nitrosomorpholine 
(NMOR) when sulphamic acid was used in sample processing are shown Table 
4.1 and in Figure 4.1. The expected and measured concentrations of  N-
nitrosomorpholine (NMOR) when 2M sodium chloride was used in sample 
processing are shown Table 4.2 and in Figure 4.2. The data represented in both 
tables is from a single experiment. 
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Table 4.1: Comparison between expected and measured N-nitrosomorpholine 
concentrations in a series of aqueous standards when 5% sulphamic acid was used 
in the sample processing. 
 
 
Vial Number 
Expected NMOR 
conc. (uM) 
Measured NMOR 
conc. (uM) 
Percentage Error
1 172 91.7 47% 
2 129 65 50% 
3 86 25.9 70% 
4 43 13 70% 
5 17.2 3.7 78% 
6 8.6 1.3 85% 
7 1.7 0.3 82% 
8 0 0 0% 
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Figure 4.1: Comparison between expected and measured N-nitrosomorpholine 
concentrations in a series of aqueous standards when 5% sulphamic acid used in 
the sample processing. 
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Table 4.2: Comparison between expected and measured N-nitrosomorpholine 
concentrations in a series of aqueous standards when 2M sodium chloride was 
used in the sample processing. 
 
Vial Number 
Expected NMOR 
conc. (uM) 
Measured NMOR 
conc. (uM) 
Percentage Error
1 172 193.7 13.% 
2 129 140.4 9% 
3 86 97.3 13% 
4 43 51 19% 
5 17.2 19.1 11% 
6 8.6 10.6 23% 
7 1.7 0.6 65% 
8 0 0 0% 
. 
 
 
 
 
 
 
 
 
 73
Figure 4.2: Comparison between expected and measured N-nitrosomorpholine 
concentrations in a series of aqueous standards when 2M sodium chloride used in 
the sample processing. 
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Use of 5% sulphamic acid in a concentrated sodium chloride solution during the 
processing of the aqueous samples resulted in significantly lower levels of N-
nitrosomorpholine being measured than would have been expected. Substitution 
of 2M sodium choride for sulphamic acid solution improved the accuracy of our 
analysis. A linear relationship existed between expected and measured 
concentrations of N-nitrosomorpholine, with satisfactory accuracy (10-23% 
expected) at all concentrations above the lowest (1.7uM). No false positive N-
nitrosomorpholine detection occurred. Use of 2M sodium chloride therefore 
appeared superior to sulphamic acid in the sample processing. 
 
4.2.5 Method for N-nitrosomorpholine sample preparation 
Following the above considerations, we were able to devise a method for 
N-nitrosomorpholine analysis: 
 
1. 40ul of fluid from each silastic tube section was added to a 1.5ml 
polypropylene vial (Eppendorf, Hamburg, Germany) containing 50ul of 2M 
sodium chloride and 10ul of 0.01%  N-nitrosodibutylamine in methanol as internal 
standard.  The vial contents were then mixed vigorously.  
2. 250ul of extraction solvent mix (45:55 dichloromethane:di-ethylether) 
was added to each vial and well mixed. To further assist separation, samples were 
then centrifuged at 3000rpm for 3 minutes.  
3. The upper (organic solvent) layer was then aspirated and transferred to a 
1.1ml flat bottomed glass vial with a tapered insert (Chromacol, Hertfordshire, 
UK). A further 250ul of fresh solvent was then added to the original vial and the 
extraction process repeated. 
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4. The resulting 300ul of organic solvent with dissolved nitrosamine was 
then concentrated to 50ul by blowing down with a gentle stream of nitrogen gas.  
5. The tapered vials were then crimp sealed and stored at -20C until 
analysis by gas chromatography: tandem mass spectrometry using the Finnigan 
PolarisQ GC/MSn Bench top Ion Trap Mass Spectrometer (Thermo Electron 
Corporation, Austin, Texas, USA). 
 
4.3 Accuracy and Precision of N-nitrosomorpholine Analysis 
Analytical considerations in the measurement of N-nitrosamines include 
minimising sample contamination during analysis and avoiding artefact 
formation. We carefully considered limiting these risks by choosing a secondary 
amine (morpholine) which does not occur naturally and by evaluating the risk of 
nitrosation during the analytical process.  
A number of factors are likely to contribute to recovery losses including 
inefficient extraction procedures and vapour loss. By measuring the concentration 
of a number of known N-nitrosomorpholine solutions following extraction from 
aqueous to organic phase we were able to confirm that the efficiency of our 
extraction process was satisfactory. Inaccuracies can also manifest within the 
GCMS/MS due to build up of debris within the column or column liner, resulting 
in poorer chromatographic peak sensitivities.  
We observed subjectively within many of our earlier GCMS analyses that 
disproportionate differences in peak height manifested over time between the 
target analyte (N-nitrosomorpholine) and the internal standard (N-
nitrosodibutylamine). This was despite routine changes of the column liner and 
inspection of the GCMS/MS column between every run. In order to minimise 
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error, we elected to simultaneously analyse a series of known concentrations of N-
nitrosomorpholine which had undergone aqueous-organic solvent extraction along 
with every set of samples from our human studies on the GCMS/MS machine. We 
utilised the same series of concentrations (0 uM, 1.7uM, 8.6uM, 17.2uM, 43uM, 
86uM, 129uM, 186uM) as we had used to assess the efficiency of the extraction 
process. This allowed us to develop a standard curve following GCMS/MS 
analysis and apply a correction factor for our unknowns. 
Table 4.3 depicts the degree of variability in analysis of the extracted N-
nitrosomorpholine standards when these standards were analysed along with the 
samples from 25 of the human subjects in the study. The variability seen was due 
to variations in the chromatography performed by the GCMS/MS machine. Using 
these standards to draw a curve in each case helped correct for this. 
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Table 4.3. Degree of variability in analysis of the extracted N-nitrosomorpholine 
standards when analysed along with samples from study subjects  
 
Expected NMOR 
concentration (uM) 
Median Measured 
NMOR concentration 
(uM) 
Interquartile range (uM) 
172 187.7 143.3-245.3 
129 145.2 114.6-177.8 
86 83.9 57.1-127 
43 39.6 25.8-74.7 
17.2 13.5 8.2-22.3 
8.6 5.8 3.7-9.5 
1.7 1.2 0.8-1.8 
0 0 0 
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4.4 Nitric oxide-mediated nitrosation within the epithelial compartment in 
vitro 
 
Before commencing our studies in humans, we wished to confirm that we were 
able to reproduce the results achieved in our previously published bench-top 
studies81. We wished to confirm: 
 
1. The ability to reproduce the previously observed nitric oxide-diated 
nitrosation in the epithelial compartment using our wider calibre 
silastic tube. 
2. Efficacy of our new method for processing and analysing N-
nitrosamines 
3. Ability of the GCMS/MS machine to confirm generation of 15N 
enriched N-nitrosomorpholine via nitric oxide following 
administration of 15N enriched nitrite to the luminal compartment. 
 
We utilised a segmented silastic tube (internal diameter 25mm, wall thickness 
5mm) to represent the epithelial cell membrane. The tube contained phosphate 
buffered saline at pH 7.4 to represent the epithelial compartment. This 
compartment also contained 25mM morpholine as a substrate secondary amine. 
The gastric lumen was represented by a glass beaker containing de-ionised water, 
0.01M hydrochloric acid, sodium thiocyanate (to final concentration 1mM), 
EDTA (to final concentration (1mM) and ascorbic acid (to final concentration 
1mM). The final pH of the gastric luminal compartment was 1.5. 
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Two glass beakers (beaker A and beaker B) containing 100ml of the 
gastric lumen solution were placed in a water bath at 37 degrees Celsius. Within 
each beaker was immersed a silastic tube partitioned into 15mm segments. Each 
tube consisted of 14 sections and was positioned such that the most peripheral 4 
sections on either side of the tube lay out-with the gastric lumen compartment and 
the central six compartments were immersed within it (figure 4.3).  The sections 
of the tube in beaker A were labelled 1-14 and the sections of the tube in beaker B 
were labelled 15-28.  
At a specified time, 1ml 10mM sodium nitrite was added to the solutions 
in beakers A and B simultaneously, creating a final concentration of 100uM nitrite 
in each. The sodium nitrite added to beaker A was 99% enriched with 15N 
whereas the sodium nitrite added to beaker B was not. The apparatus is depicted 
in figure 10. The reaction was allowed to proceed for 30 minutes, after which the 
silastic tube was removed from each beaker and the contents of each analysed for 
nitrite and N-nitrosomorpholine.  
Sections 1-4 and 11-14 of the tube in beaker A and sections 15-18 and 25-
28 of the tube in beaker B were not immersed in the gastric lumen solution and 
nitrite and N-nitrosomorpholine were not detected within these sections. Sections 
5-10 and 19-24 were immersed in the beaker solutions and nitrite and N-
nitrosomorpholine concentrations measured in each are shown in table 4.4. 
Generation of nitric oxide in each beaker following administration of 
nitrite was confirmed using a nitric oxide sensor (ISO:NO Mark II: World 
Precision Instruments Inc., Sarasota, Florida). 
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Figure 4.3:  Experiment to confirm nitric oxide-mediated nitrosation within the 
epithelial compartment of segmented silastic tube with wall thickness 5mm and 
internal diameter 25mm. Two tubes comprising 15 segments are partially 
immersed into beakers A and B, which comprise a chemical stomach model. 15N 
enriched sodium nitrite is added to beaker A and standard sodium nitrite is added 
to beaker B. 
 
 
A
A
C D
B
HCl pH 1.5
1mM Ascorbic Acid
1mM Thiocyanate
1mM EDTA
HCl pH 1.5
1 mM Ascorbic Acid
1 mMThiocyanate
1 mM EDTA
1ml 10mM 
15N KNO2
F
1ml 10mM
KNO2
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Table 4.4: Silastic tube fluid concentrations of nitrite, N-nitrosomorpholine and 
15N enrichment of N-nitrosomorpholine for the sections exposed to acidified 
nitrite and ascorbic acid.  Sections 5-10 were exposed to 15N enriched nitrite and 
sections 19-24 to standard nitrite. 
 
Section Number 
Nitrite conc. 
(uM) 
NMOR conc. 
(uM) 
NMOR 15N 
enrichment 
NMOR: Nitrite 
ratio 
5 378 55.3 99% 0.15 
6 498 91.7 99% 0.18 
7 522 88.4 99% 0.17 
8 618 84.5 99% 0.14 
9 654 76.9 99% 0.12 
10 392 40.1 99% 0.1 
     
19 316 52.8 0% 0.17 
20 588 94.8 0% 0.16 
21 438 82.4 0% 0.19 
22 502 83.9 0% 0.17 
23 558 108.1 0% 0.19 
24 420 72.5 0% 0.17 
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Only sections 6-9 and sections 20-23 were constantly exposed to acidified nitrite 
during the experiment, as sections 5, 10, 19 and 24 were only partially submerged. 
Median nitrite concentration for those sections constantly exposed to acidified 
nitrite and ascorbic acid was 570uM and median N-nitrosomorpholine for those 
sections was 86.4uM. The sections exposed to 15N enriched nitrite were 99% 
enriched with 15N and the sections exposed to standard nitrite were not enriched. 
In this experiment, both ascorbic acid and dissolved oxygen were present in 
excess of nitrite, therefore the vast majority of nitrite entering the epithelial 
compartment will be in the form of nitric oxide. The median N-nitrosomorpholine 
ratio, an expression of the proportion of nitrosation occurring as a result of nitric 
oxide versus nitrous acid, was 0.17. 
This experiment has confirmed that our wider bore silastic tube can be 
used to determine nitrite and N-nitrosomorpholine generation within an epithelial 
model exposed to nitric oxide formed by reaction of acidified nitrite and ascorbic 
acid and  that, using GCMS/MS,  we are able to determine if measured N-
nitrosomorpholine is enriched with 15N. 
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CHAPTER FIVE  
 
IN SITU GENERATION OF N-NITROSO COMPOUNDS IN THE UPPER 
GASTROINTESTINAL TRACT OF HUMAN HEALTHY VOLUNTEERS 
FOLLOWING INGESTION OF NITRATE 
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5.1 Introduction 
 This study was designed to investigate if the ingestion of nitrate generated 
in situ nitrosative stress within our epithelial model located in the human upper 
gastro-intestinal tract, and to ascertain the maximal location of any stress 
measured. To examine this we studied healthy human volunteers after ingestion of 
nitrate and after ingestion of de-ionised water as a control drink. The nitrate 
administered was 99% enriched with the heavy, stable nitrogen isotope 15N, 
which accounts for only 0.366% of all nitrogen occurring naturally 
 This chapter documents the methods and results for this study in healthy 
human volunteers. The results will be discussed along with the results from the 
study in patients with Barrett’s oesophagus in Chapter Seven. 
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5.2 Materials and Methods 
 
5.2.1 Subjects studied 
17 healthy volunteers (11 males, median age 27) with no history of reflux 
disease were studied on 2 separate days following an overnight fast.  All tested 
negative for Helicobacter pylori  
H. pylori status was determined using the 14C urea breath test. This test has 
previously been validated in our unit and, using a cut off value of 30 (kg %dose 
mmol-1) for the 20 minute results, has a sensitivity of 98% and specificity of 
100%. 
 
5.2.2 Methods 
As described earlier, we employed silastic tubing (Altec, Cornwall, UK), 
with internal diameter 2.5mm and wall thickness 0.5mm for our in-situ epithelial 
model. A 100cm section of tubing was filled with the secondary amine 
morpholine, which was buffered at intracellular pH (7.4) using 2mM phosphate 
buffer. The tubing was then partitioned into 21 sections, each 15mm long, by 
twisting twice and then tying with 4-0 vicryl suture (Ethicon Corporation, 
Somerville, New Jersey, USA). Every section contained approximately 74ul. This 
length of tubing was attached to a customized 4 channel pH catheter (Synectics 
Medical, Middlesex, UK) in order that we could simultaneously monitor luminal 
acidity. The pH sensors were aligned to centre of the 19th, 14th, 13th and 8th 
sections of the silastic tube respectively, and attached by tying with vicryl suture 
and securing with Sleek® waterproof tape (figure 5.1). A 5cm length of 10F 
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gastric tube (Vygon, Ecouen, France) containing a radio-opaque marker was 
secured to the distal end of the pH catheter to assist passage.  
 Subjects attended the gastro-intestinal investigation unit on 2 separate days 
following an overnight fast. On each study day, the tube was passed naso or oro-
gastrically. The tube was positioned such that sections 1-13 lay within the 
oesophagus and sections 14-21 lay within the stomach. This was achieved by 
monitoring the pH step-up and confirmed by X-ray (Figure 5.2). 30 minutes after 
insertion of the tube, the subjects were administered the study drink. On one day, 
the subjects drank 60 ml of water containing 2 mmoles potassium nitrate and on 
the other 60ml of water without nitrate. 8 of the subjects received nitrate which 
was 99% enriched with the heavy, stable isotope 15N (Sercon Ltd, Nantwich, UK). 
The order in which the different drinks were administered was random. 
The tube remained in-situ for 2 hours after the drink, with pH being 
monitored at each site every 4 seconds.  Immediately prior to the drink, and at 15 
minute intervals following it, 10 ml blood and 1ml saliva samples were collected 
for measurement of serum nitrate and salivary nitrite concentrations. The tube was 
then removed and each section carefully aspirated using a 100ul glass syringe 
(SGE, Milton Keynes, UK). 10ul was used for measurement of silastic tube nitrite 
concentration and 40ul for analysis of silastic tube N-nitrosomorpholine 
concentration.  
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Figure 5.1: Photograph of region of segmented silastic tube attached to pH 
catheter. Each section contains morpholine 25mM buffered at pH 7.4 and is 
15mm in length. Section 10 is apposed to probe 1 and sections 13 and 14 to 
probes 2 and 3 respectively. 
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Figure 5.2:  Plain postero-anterior chest X ray of specialized oesophago-gastric 
tube in-situ within the upper gastro-intestinal tract of a human healthy volunteer. 
Sections 13 and 14 are apposed to probes 2 and 3 and lie on either side of the pH 
step up point. Section 10 is apposed to probe 1 and positioned 5cm proximal to 
the pH step up point. Section 19 is apposed to probe 4 and section 21 lies 12cm 
inside the stomach, apposed to a radio-opaque marker. 
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5.2.3 Analyses 
 
5.2.3.1 Salivary and silastic tube nitrite concentration 
 
It was important that any fluid to be analysed for nitrite concentration was 
not at acid pH, avoiding loss as nitric oxide following pH dependent conversion to 
nitrous acid and nitrosating species. 10ul of silastic tube solution (pH 7.4) was 
diluted to 1:10 prior to colorimetric analysis by adding 90ul of de-ionised water. 
1ml of saliva was alkalinised and diluted to 10:11 by addition of 1M sodium 
hydroxide.  
Samples were analysed against known concentrations of nitrite in a 96 
microwell plate, using the modified Greiss reaction for nitrite analysis, as 
previously described 103, 126. Greiss reagent consists of sulphanilamide, 
hydrochloric acid and NEDD (N-1-Napthylethylenediaminedihydrocholide). 
Presence of nitrite in an acidic environment leads to production of an azo dye that 
is detected via its absorbance on a plate reader at 540nm.  
 
5.2.3.2 Serum nitrate concentration 
Thirty minutes after collection, blood samples were centrifuged at 
3000rpm for 3 minutes. Serum was removed and stored at -20 degrees Celsius 
until nitrate analysis. After thawing, serum samples were filtered through a 10kDa 
microfilter (Microcon 10; Millipore UK Ltd, Watford, UK) to remove high 
molecular weight substances. Nitrate was reduced to nitrite using bacterial nitrate 
reductase, as previously described 103. Nitrite was then measured by Greiss 
reaction as stated above. 
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5.2.3.3 Silastic tube N-nitrosomorpholine concentration 
10ul of silastic tube solution was utilised for measurement of N-
nitrosomorpholine concentration as described on page 72. To facilitate direct 
comparison between N-nitrosomorpholine concentrations from the same silastic 
tube section on the two study days, the auto-sampler carousel was arranged such 
that the corresponding sections were analysed in sequence. As described on page 
74, a series of extracted samples of known un-extracted concentrations of N-
nitrosomorpholine were analysed on the same run as each subject’s samples. This 
allowed calculation of a standard curve against which to compare the 
concentrations from the subject’s samples. 
 
5.2.4 Statistical analyses 
 All data is presented as medians (Interquartile range). Paired data were 
analysed using a one sample Wilcoxon test, and unpaired data by Mann-Whitney 
U test.  
Total nitrite and N-nitrosomorpholine within the silastic tube were 
calculated from the area under the curve on the graph comparing concentration of 
each compound by location. Area under the curve was estimated using the 
trapezoid method, and a volume correction factor (x 0.074) applied. 
Calculations were performed using Minitab ® Release 14 statistical 
software. 
 
5.2.5 Ethical approval 
The study was approved by North Glasgow NHS Trust Ethics Committee 
and each subject gave written, informed consent. 
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5.3 RESULTS 
 
16 of the 17 subjects completed both arms of the study. One subject was 
achlorhydric (intragastric pH >4.0), and was later confirmed to be H. pylori-
positive by serological testing after an initial negative breath test. 
 
5.3.1 Serum nitrate 
Prior to administration of the study drink, median serum nitrate concentration 
was 11.0 (7.2-13.8) uM on the day when the control drink was administered, not 
significantly different from 9.1 (7.5-13.9) uM on the day when the nitrate drink 
was administered. Following administration of 2 mmoles potassium nitrate, there 
was a large and significant rise in serum nitrate concentration (p=0.001), which 
peaked at 33.1(21.9-56.5) uM after 45 minutes and remained at this level for the 
duration of the study. Following administration of the control drink, serum nitrate 
concentration did not change from basal, remaining at 11.1(6.0-15.3) uM after 45 
minutes (Figure 5.3) 
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Figure 5.3: Median serum nitrate concentration with time (in minutes) for 15 
healthy volunteers. Black dots represent concentrations following the control 
drink and red dots represent concentrations following the nitrate drink. Whiskers 
depict interquartile ranges. 
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5.3.2 Salivary nitrite 
 Prior to administration of the study drink, median salivary nitrite 
concentration was 51.4 (24.7-79.4) uM on the day when the control drink was 
administered, not significantly different from 48.7 (24.8-77.3) uM on the day 
when the nitrate drink was administered.  Following administration of 2mmoles 
potassium nitrate, there was a large and significant rise in salivary nitrite 
concentration (p=0.001), which peaked at 331.8 (265.5-575) uM after 75 minutes 
and remained at almost this level for the duration of the study. After 
administration of the control drink, salivary nitrite concentration changed little 
from basal, remaining at 59 (32-122.3) uM at 75 minutes (Figure 5.4). 
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Figure 5.4: Median salivary nitrite concentration with time (in minutes) for 15 
healthy volunteers. Black dots represent concentrations following the control 
drink and red dots represent concentrations following the nitrate drink. Whiskers 
depict interquartile ranges. 
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5.3.3 Silastic tube nitrite 
The diffusion of either nitric oxide or nitrous acid through the wall of the tube 
forms nitrite within the tube. Nitrite was not detected within the tube sections 
lying within the oesophagus. However, nitrite was present in the sections exposed 
to gastric acid on both study days. The median total nitrite formed within the 
silastic tube was 17.3 (7.9-28.5) nmoles on the control day and 62.1 (40.8-110.3) 
nmoles on the day when potassium nitrate was administered (p=0.001).  The 
concentration profile along the gastric sections of the tube was similar on both 
study days, with the highest concentrations being detected in sections 15 and 16 
(figure 5.5), which are the first sections likely to be constantly exposed to 
intragastric acidity. We have observed using fluoroscopic screening that the 
excursion of the oesophago-gastric junction with normal respiration is 3-4cm. The 
probe at section 13 showed pH <2 for 7% of the time and the probe at section 14 
showed pH <2 for 63% of the time. Peak concentrations of nitrite were detected in 
section 16, being 48 (13.8-68.3) uM after the control drink and increasing over 
three-fold to 159 (93-264) uM following nitrite. Our one subject who was 
achlorhydric had no detectable nitrite in any of the silastic tube sections.  
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Figure 5.5: Median silastic tube nitrite concentration by location for 15 
healthy volunteers. Sections 1-13 lie above the pH step up point and 14-21 
below the pH step up point. The grey broken vertical line between sections 13 
and 14 represents the pH step up point, and the surrounding rectangle 
represents the range of excursion of the pH step up point with normal 
respiration.  Results following administration of the control drink are 
represented by () and following administration of 2 mmoles nitrate by (J). 
Whiskers represent interquartile ranges. 
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5.3.4 Silastic tube N-nitrosomorpholine 
N-nitrosomorpholine was not detected within the oesophageal sections of the 
silastic tube. However, it was detected in the sections exposed to gastric acid 
when subjects had taken either the control drink or the nitrate drink. The median 
total N-nitrosomorpholine formed within the silastic tube was 2.3 (0.8-3.2) nmoles 
on the control day and 4.5 (2.7-7.9) nmoles on the day potassium nitrate was 
administered (p=0.008). On the control day, peak N-nitrosomorpholine 
concentration was 6.1 (1.7-8.5) uM, measured in section 16. However, following 
the nitrate the N-nitrosomorpholine concentration profile was different, producing 
a plateau rather than the peak concentration recorded without nitrate (Figure 5.6). 
N-nitrosomorpholine concentration in section 16 was 7.3 (5.3-12.7) uM following 
nitrate, not much greater than after the control drink. Peak N-nitrosomorpholine 
concentration after nitrate was measured in section 19, where the concentration of 
8.9 (4.2-17.7) uM was over three-fold greater than 2.7 (0-4.5) uM detected in this 
section following the control drink. Our one subject who was achlorhydric had no 
detectable N-nitrosomorpholine in any of the silastic tube sections. 
Eight of the healthy volunteers were administered nitrate which was 99% 
enriched with the heavy nitrogen isotope 15N. The N-nitrosomorpholine in these 
volunteers had a median enrichment of 77.4% (64.4-87.3) after administration of 
nitrate, compared with no enrichment when the control drink was administered. 
This confirmed that the excess N-nitrosomorpholine formed following 
administration of nitrate originated from the ingested nitrate. 
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Figure 5.6: Median silastic tube N-nitrosomorpholine (NMOR) concentration by 
location for 15 healthy volunteers. Sections 1-13 lie above the pH step up point 
and 14-21 below the pH step up point.  The grey broken vertical line between 
sections 13 and 14 represents the pH step up point, and the surrounding rectangle 
represents the range of excursion of the pH step up point with normal respiration. 
Results following administration of the control drink are represented by () and 
following administration of 2 mmoles nitrate by (J). 
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5.3.5 Correlation of silastic tube nitrite versus N-nitrosomorpholine 
The ratio of N-nitrosomorpholine: nitrite within the silastic tube is an 
expression of nitric oxide: nitrite in the lumen of the gastro-intestinal tract.  N-
nitrosomorpholine can only be formed within the epithelial compartment by the 
diffusion of nitric oxide, whereas nitrite can be formed via the diffusion of either 
nitric oxide or nitrous acid into the tube 81.  
Administration of nitrate resulted in a three-fold increase in peak silastic tube 
nitrite concentrations, but only a 50% increase in peak N-nitrosomorpholine 
concentrations. We calculated the ratio of N-nitrosomorpholine: nitrite 
concentrations for each silastic tube section in all of the healthy volunteers. The 
median of all ratios of N-nitrosomorpholine: nitrite concentration following nitrate 
ingestion was 0.064 (0.045-0.099), significantly lower than 0.11 (0.052 – 0.43) 
following the control drink (p = 0.02).   
 
 
 
 
 
 
 
 
 
 100
  
 
CHAPTER SIX  
 
THE INFLUENCE OF GASTRO-OESOPHAGEAL ACID REFLUX ON 
THE MAXIMAL LOCATION OF NITROSATIVE STRESS IN SUBJECTS 
WITH BARRETT’S OESOPHAGUS 
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6.1 INTRODUCTION 
This study was designed to investigate the influence of acid reflux on the maximal 
location of in situ nitrosative stress following ingestion of nitrate within an 
epithelial model positioned in the human upper gastrointestinal tract. 
To facilitate this aim, we elected to study patients with Barrett’s 
oesophagus, as these are individuals who have significant and measurable gastro-
oesophageal reflux disease139 in whom reflux can be readily stimulated106.  All 
subjects ingested 2 mmoles of potassium nitrate and were studied on two separate 
days. On one day we attempted to stimulate gastro-oesophageal acid reflux and on 
the other day we did not. 
This chapter documents the methods and results for this study in patients 
with Barrett’s oesophagus. The results will be discussed along with the results 
from the study in healthy volunteers in Chapter Seven. 
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6.2 MATERIALS AND METHODS 
6.2.1 Subjects studied 
18 H. pylori-negative patients with Barrett’s oesophagus (13 males, mean 
age 61) were recruited from our gastroenterology clinic. The median length of the 
Barrett’s mucosa was 6cm (range 2cm – 20cm). In some patients, H. pylori status 
had already been confirmed by negative 14C urea breath test, serology, histology 
or CLO test. In other patients in whom H pylori status was unknown, 14C urea 
breath test was performed after a 7 day cessation of proton pump inhibitor 
therapy. 
 Proton pump inhibitors (PPIs) were stopped 7 days prior to investigation 
to allow time for recovery of gastric acid secretion. Our choice of 7 days post PPI 
treatment in these H. pylori-negative subjects was based upon our previous 
published work showing that this is the time point most representative of the pre-
PPI acid secretion. At an earlier time point, inhibitory effects may persist and at a 
later time rebound secretion becomes more marked 140, 141. 
 
6.2.2 Methods 
As described earlier, we employed silastic tubing (Altec, Cornwall, UK), 
with internal diameter 2.5mm and wall thickness 0.5mm for our in-situ epithelial 
model. The silastic tube was partitioned into sections of 15mm length and 
attached to a 4 channel pH catheter as described on page 82. 
Patients attended the gastro-intestinal investigation unit on two occasions 
after an overnight fast. At the first visit, gastro-intestinal endoscopy was 
performed either consciously using lignocaine local anaesthetic spray or under 
conscious sedation using intravenous midazolam. The extent of the Barrett’s 
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mucosa was inspected and two stainless steel mucosal clips (MD-59; Olympus, 
Southend-on-Sea, UK) were placed at the proximal margin of the gastric folds to 
mark the anatomical gastro-oesophageal mucosal junction (figure 6.1) Unlike in 
healthy volunteers, where the pH step-up point is a reliable indicator of the 
squamo-columnar junction 69, in the patients with Barrett’s oesophagus we 
required a radiological marker to demonstrate this anatomical site. In the first few 
patients with Barrett’s oesophagus, clips were also deployed at the proximal 
margin of the segment of columnar lined mucosa. However, this was abandoned 
laterally as it prolonged the time of the endoscopic procedure and was 
uncomfortable for patients with very long Barrett’s segments.  
One hour following endoscopy, the specialised silastic tube was passed 
naso or oro-gastrically. It was positioned such that sections 1-13 were proximal 
and 14-21 distal to the gastro-oesophageal junction, as demonstrated by the radio-
opaque clips on lateral chest X-ray (figure 6.2). The probe was placed in an 
identical position on the second study day, again using the radio-opaque clips 
which remained attached. 
The study days were designed to maximize and minimize acid reflux. On 
one day, we studied the patients in the sitting position without attempt to stimulate 
reflux. On the other visit, we attempted to stimulate acid reflux by placing the 
subjects in the right lateral decubitus position, with or without the head down 
position, and infusing a low dose of pentagastrin (0.06ug/kg/h) (Cambridge 
Laboratories, Wallsend, UK) intravenously to stimulate physiological levels of 
acid secretion. On each study day, once the tube was satisfactorily positioned, 
subjects drank 60ml water containing 2mmoles potassium nitrate. Twelve subjects 
received nitrate which was 99% enriched with 15N on both study days. The probe 
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remained in-situ for 2 hours following the drink, with blood and saliva samples 
for nitrate and nitrite collected at 15 minute intervals. Luminal pH adjacent to the 
4 probes was recorded every 4 seconds for the duration of the study. The position 
of the tube was confirmed radiologically immediately prior to its removal. Each 
section of the tube was aspirated for analysis of nitrite and N-nitrosomorpholine 
concentration as discussed earlier. 
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Figure 6.1: Endoscopic view of stainless steel mucosal clips deployed at the top of 
the gastric folds in a patient with columnar lined oesophagus. 
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Figure 6.2: Lateral chest X ray depicting proximity of specialized oesophago-
gastric tube to mucosal clips marking the gastro-oesophageal junction in a patient 
with 3cm of columnar lined oesophagus. 
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6.2.3 Chemical analyses 
 As in the healthy volunteers, we measured serum nitrate, salivary nitrite, 
silastic tube nitrite and silastic tube N-nitrosomorpholine. The analytical methods 
are as described in chapter 5. 
 
6.2.4 Statistical analyses 
All data is presented as medians (Interquartile range). Paired data were 
analysed using a one sample Wilcoxon test, and unpaired data by Mann-Whitney 
U test.  Spearman’s rank test was employed to assess correlation when examining 
the relationship between oesophageal acid reflux and nitrosative stress in that 
region.  
Calculations were performed using Minitab ® Release 14 statistical 
software. 
 
6.2.5 Ethical approval 
The study was approved by North Glasgow NHS Trust Ethics Committee 
and each subject gave written, informed consent. 
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6.3 RESULTS 
 
 
Eighteen patients with Barrett’s oesophagus were recruited. One patient was 
unable to tolerate the oesophago-gastric tube and withdrew from the study. One 
further patient completed both arms of the study but produced very little saliva. 
This was probably as a results of the patient having psoriatic arthropathy, which 
has a recognized association with  reduced salivary flow142.  Results from 16 
patients were included in the analysis.  
 
6.3.1 Gastro-oesophageal acid reflux 
Gastro-oesophageal acid reflux was defined as pH <4 detected 5cm proximal 
to the clips marking the top of the gastric folds (the anatomical gastro-
oesophageal junction). pH was <4 at this location for a median of 14.5% (IQ 
range 2.6-48.7%) of 32 study days. On the 16 study days when reflux was 
stimulated by postural and pharmacological methods, pH was less than 4 at this 
location for a median of 40% (IQ range 14.3-63.6%). This was significantly 
higher than the 3.6% (0.1-19%) when reflux was not stimulated (p=0.003) which 
was in turn significantly higher than 0.1% (0-1.0%) in the healthy volunteers who 
received nitrate (p = 0.03). 
 
6.3.2 Serum nitrate 
Prior to administration of the study drink, median serum nitrate concentration 
was 11.3 (7-13.4) uM on the day when reflux was not provoked, not significantly 
different from 7.8 (5.8-13.4) uM on the day we provoked reflux.  Following 
administration of 2mmoles of potassium nitrate, serum nitrate concentrations 
 109
increased almost four fold on both days, peaking after 60 minutes at 43.1 (30.4-
50.6) uM on the day when reflux was not provoked and 37.5 (24-48.6) uM on the 
day we provoked reflux (Figure 6.3). Basal and peak nitrate concentrations in 
patients with Barrett’s oesophagus were not significantly different from the 
healthy volunteers. 
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Figure 6.3: Median serum nitrate concentration with time for 16 Barrett’s 
oesophagus patients. Black dots represent concentrations on the day reflux was 
not provoked and red dots represent concentrations on the day we provoked 
reflux. Whiskers depict interquartile ranges. 
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6.3.3 Salivary nitrite 
Prior to administration of the study drink, median salivary nitrite 
concentration was 38.2 (16.4-70.7) uM on the day when reflux was not provoked, 
not significantly different from 59.2 (41 – 90.1) uM on the day we provoked 
reflux.  Following administration of 2mmoles of potassium nitrate, salivary nitrite 
concentrations increased significantly on both days, peaking at 578 (271-666) uM 
after 90 minutes on the day when reflux was not provoked and at 457.7 (307-
572.6) uM after 60 minutes on the day we provoked reflux (figure 6.4). Basal and 
peak salivary nitrite concentrations in patients with Barrett’s oesophagus were not 
significantly different from the healthy volunteers. 
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Figure 6.4: Median salivary nitrite concentration with time for 16 Barrett’s 
oesophagus patients. Black dots represent concentrations on the day reflux was 
not provoked and red dots represent concentrations on the day we provoked 
reflux. Whiskers depict interquartile ranges. 
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6.3.4 Silastic tube nitrite 
On the day that reflux was stimulated in the patients with Barrett’s 
oesophagus, a median of 33% (17.13 – 54.9%) of the total nitrite formed within 
the silastic tube was formed within the oesophageal sections. This was a 
significantly greater proportion than 8.1% (1.5 – 31.8%) when reflux was not 
stimulated (p= 0.01). In the healthy volunteers who received nitrate, the 
proportion of nitrite present within the oesophagus was 0.7 % (0-2.5%), which 
was significantly lower than the Barrett’s patients in whom reflux was not 
stimulated (p=0.007). 
The concentration profile of nitrite along the length of the tube in the 32 
studies from 16 Barrett’s patients correlated with the frequency of reflux. A linear 
relationship existed between the duration of acid reflux (proportion of the study 
that pH was <4 at 5cm above the gastro-oesophageal junction) and the proportion 
of the total nitrite that was formed within the oesophageal sections (Spearman ρ 
0.927, p < 0.01), with 80% of the nitrite being formed within the oesophagus 
during reflux. (figure 6.5) 
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Figure 6.5: Fitted line plot comparing percentage of time pH <4 5cm above the 
gastro-oesophageal junction (marked by the clips at the top of the gastric folds) 
with the proportion of total nitrite formed within the oesophageal sections 
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6.3.5 Silastic tube N-nitrosomorpholine 
On the day that reflux was stimulated in the patients with Barrett’s 
oesophagus, a median of 29% (6.9– 50.5%) of the total N –nitrosomorpholine 
formed within the silastic tube was formed within the oesophageal sections. This 
was significantly greater than 5.1% (0 – 24%) on the day when reflux was not 
stimulated (p<0.001). In the healthy volunteers who received nitrate, the 
proportion of N –nitrosomorpholine present within the oesophagus was 1.6 % (0-
5.1%), which was lower than the Barrett’s patients in whom reflux was not 
stimulated.  
From 28 studies in 14 Barrett’s patients, a linear relationship existed between 
the duration of acid reflux and the proportion of the total N-nitrosomorpholine that 
was formed within the oesophageal sections (Spearman’s ρ 0.75, p <0.01), with 
80% being formed in the oesophagus during reflux. (figure 6.6) 
Twelve patients with Barrett’s oesophagus were administered nitrate that was 
99% enriched with the heavy nitrogen isotope 15N on each study day. Median 
enrichment was 74.6% (59-83.1), confirming that the N-nitrosomorpholine 
formed was derived from the nitrate ingested. 
 
 
 
 
 
 
 
 116
Figure 6.4: Fitted line plot comparing percentage of time pH <4 5cm above the 
gastro-oesophageal junction (marked by the clips at the top of the gastric folds) 
with the proportion of total N-nitrosomorpholine formed within the oesophageal 
sections. 
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6.3.6 Correlation of silastic tube nitrite versus N-nitrosomorpholine 
We calculated the ratio of N-nitrosomorpholine: nitrite concentrations for 
each silastic tube section in all of the subjects with Barrett’s oesophagus. The 
median of all ratios of N-nitrosomorpholine: nitrite concentration was 0.053 
(0.026-0.089) for the gastric sections. This was significantly higher than 0.028(0-
0.06) for the oesophageal sections (p<0.001), but not significantly different from 
0.064 (0.045 - 0.099) for the gastric sections of the healthy volunteers who had 
received nitrate.  This finding indicates that a greater proportion of the nitrite 
measured within the oesophagus was generated via nitrous acid compared with 
the stomach. Median N-nitrosomorpholine concentration as a percentage of nitrite 
concentration by location is depicted in figure 6.7. 
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Figure 6.7: Median ratio of N-nitrosomorpholine: nitrite by location in the upper 
GI tract in patients with Barrett’s oesophagus.  
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Our studies demonstrate a novel mechanism by which dietary nitrate may induce 
nitrosative stress and generate N-nitroso compounds within the upper 
gastrointestinal tract of subjects with healthy acid-secreting stomachs.  This 
mechanism is via the generation of nitric oxide formed when nitrite in saliva 
encounters acidic gastric juice containing reducing agents such as ascorbic acid. 
The nitric oxide formed in this way can diffuse from the lumen into an adjacent 
compartment of neutral pH and, within it, combine with oxygen to form the 
nitrosating species N2O3.   
 The potential for generation of N-nitroso compounds within the lumen of 
the acidic stomach has been recognised for many years 95, 143.  This is due to the 
large amounts of nitrite constantly delivered into the stomach in swallowed saliva 
72, 87.  The nitrite in saliva is derived from the entero-salivary recirculation of 
dietary nitrate and its reduction to nitrite by buccal bacteria 86, 87, 144.  When the 
nitrite encounters the acidic pH of gastric juice at the gastric oesophageal 
junction, it is immediately converted to nitrous acid and nitrosating species such 
as NO+, NOSCN and N2O3.  The latter can react with secondary amines to form 
potentially carcinogenic N-nitroso amines.  The main factor protecting against this 
acid catalysed N-nitrosation is ascorbic acid 93 which effectively competes with 
secondary amines for the nitrosating species.  In this reaction between the 
nitrosating species and ascorbic acid, the former is reduced to nitric oxide and the 
latter oxidized to dehydroascorbic acid.  In this previously recognised pathway of 
acid catalysed nitrosation, the reaction between the nitrosating species and 
ascorbic acid has been regarded as entirely protective by preventing the generation 
of N-nitroso compounds within the acidic lumen.  However, our current studies 
demonstrate that the nitric oxide formed from the reaction between ascorbic acid 
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and acidified nitrite can induce nitrosative stress and the generation of N-nitroso 
compounds within an adjacent compartment of neutral pH. 
 How do we know that the N-nitrosomorpholine generated in-situ within 
the epithelial compartment was formed via nitric oxide and not by the direct 
reaction between morpholine and the nitrosating species formed by the 
acidifications of salivary nitrite?  In our previously published bench top studies 81, 
we examined the generation of N-nitrosomorpholine within the silastic tube when 
its exterior surface was exposed to the chemical conditions occurring within the 
lumen of the human proximal stomach.    The amount of N-nitrosomorpholine 
formed inside the silastic tube was directly proportional to the nitric oxide 
concentration generated in the luminal compartment to which the external surface 
of the tube was exposed. If the luminal compartment contained only nitrite and 
hydrochloric acid then the nitrosating species formed in this solution only 
generated N-nitrosomorpholine in the same luminal compartment and not in the 
epithelial compartment. However, the further addition of ascorbic acid to the 
luminal compartment prevented nitrosation in this compartment and produced 
high concentrations of nitric oxide in the luminal compartment and high 
concentrations of N-nitrosomorpholine in the epithelial compartment. This, 
therefore, indicates that the N-nitrosomorpholine generated within the silastic tube 
is derived from nitric oxide entering the tube and not from acid catalysed 
nitrosating species entering the tube. 
 How do we know that the N-nitrosomorpholine generated within the tube 
was derived from the administered nitrate?  The administration of nitrate 
increased the concentration of N- nitrosomorpholine formed in the silastic tube in 
the healthy volunteers. Further confirmation of the origin of this N-
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nitrosomorpholine was obtained by administering 15N nitrate to 8 of our healthy 
volunteers and 12 of our patients with Barrett’s oesophagus. In these subjects, we 
found that 75% of the N-nitrosomorpholine formed within the tube was enriched 
with 15N.  This demonstrates that the administered nitrate had been absorbed from 
the gastrointestinal tract, taken up the salivary glands and secreted into the mouth, 
reduced to nitrite by buccal bacteria, swallowed in saliva, converted to nitrous 
acid and nitrosating species when encountering acidic gastric pH and converted to 
nitric oxide by ascorbic acid or other reducing agents within the stomach. The 
nitric oxide generated was then able to pass through the gas permeable silastic 
wall of the tube and, within that neutral pH environment, react with oxygen to 
form N2O3 which in turn reacted with the secondary amine to form N-
nitrosomorpholine.   
 In addition to N-nitrosomorpholine, we also detected substantial amounts 
of nitrite within the silastic tube exposed to gastric acidity.  Our previous studies 
have indicated two mechanisms by which nitrite can accumulate within the 
silastic tube exposed to conditions occurring within the lumen of the human upper 
gastrointestinal tract.  The first and major mechanism is by nitric oxide formed 
from the reaction between nitrosating species and ascorbic acid, diffusing through 
the wall of the tube and then reacting with O2 to form the nitrosating species 
N2O3.  The latter can then react either with the secondary amines to form N-
nitrosamines as described above or can react with water to form nitrite (N2O3 + 
H2O --> 2 NO2- +  2 H+). The second mechanism by which nitrite may accumulate 
within the tube is due to nitrous acid diffusing through the wall of the tube. 
Nitrous acid is a weak acid (HNO2  H+ + NO2- : pKa = 3.34) and at 
intragastric pH it exists predominantly as the relatively non-polar molecule HNO2 
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which will be able to pass through the wall of the silastic tube. Nitrous acid is a 
much larger molecule than nitric oxide and thus passes through the silastic tube 
wall much more slowly. When the nitrous acid passes through the wall of the 
silastic tube and encounters the solution of neutral pH within the silastic tube, it is 
immediately converted to nitrite. Unlike nitric oxide, nitrous acid does not form 
N2O3 or other nitrosating species required for the formation of N-nitroso 
compounds within the neutral pH environment of the tube. In addition, when 
nitrous acid diffuses through the wall of the tube, it does not result in the 
generation of N-nitrosocompounds within the tube.  This is due to the fact that 
nitrous acid only forms nitrosating species at acidic pH. The ratio of N-
nitrosomorpholine to nitrite formed within the tube indicates the extent to which 
the nitrite added to the acidic luminal compartment has been converted to nitrous 
acid and nitrosating species versus nitric oxide.  When ascorbic acid is present in 
abundance in the luminal compartment causing all the added nitrite to be 
converted to nitric oxide, then the ratio is 0.1- 0.2 (median of 0.17 in our bench-
top studies from this thesis [chapter 4, page 67]) . In contrast, when there is no 
ascorbic acid in the surrounding medium and any nitrite added is in the form of 
nitrous acid or nitrosating species, then the ratio is less than 0.01 as almost no N-
nitrosomorpholine is formed 81. 
 In the present study, administration of nitrate to the healthy volunteers not 
only increased the production of N-nitrosomorpholine and nitrite within the tube 
but also reduced the ratio of N-nitrosomorpholine to nitrite within the tube.  This 
can be explained by the increase in nitrite in swallowed saliva following nitrate 
administration not all being converted to nitric oxide in the proximal stomach but 
some remaining in the form of nitrous acid and nitrosating species.  This will 
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happen if the increased nitrite load overwhelms the gastric juice concentrations of 
ascorbic acid and its ability to reduce all the nitrous acid and nitrosating species to 
nitric oxide.  This means that following the nitrate administration, there were 
nitrosating species within the lumen of the gastrointestinal tract and thus the 
potential for generation of N-nitroso compounds by the previously well 
recognised acid-catalysed luminal chemistry. 
The design of our silastic tube also enabled us to investigate the 
anatomical location of the nitrosative chemistry occurring throughout the upper 
gastrointestinal tract and its correlation with luminal pH.  In the healthy 
volunteers with or without nitrate administration, no nitrite or N-
nitrosomorpholine was formed in the segments located in the oesophagus and not 
exposed to gastric acid.  Without nitrate administration both nitrite and N-
nitrosomorpholine were formed in the segments exposed to the acidic gastric 
environment and the concentrations of both were highest in the most proximal 
segments constantly exposed to intragastric acidity. Following nitrate 
administration, the peak nitrite concentration was again evident in the proximal 
stomach but the N-nitrosomorpholine formed more of the plateau.  There was 
therefore a tendency for the ratio of nitrite to N-nitrosomorpholine to be lower in 
the proximal stomach following the administration of nitrate.  This may be 
explained by the higher amounts of nitrite delivered into the proximal stomach 
following the nitrate, exhausting the ascorbic acid concentration in the most 
proximal stomach and allowing nitrite to enter as nitrous acid rather than as nitric 
oxide.   We have previously observed that the ratio of nitrite to ascorbic acid is 
highest in the most proximal stomach 126.  
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 One of the healthy volunteers was found to be achlorhydric.  In this 
subject, no nitrite and no N-nitrosomorpholine was detected in any of the tube 
segments.  This highlights the key role of acid in forming nitrosating species 
within the lumen and subsequently in generating nitric oxide which may form N-
nitrosomorpholine within the silastic tube.  There is of course a third mechanism 
of N-nitrosation and which may occur in the achlorhydric stomach.  This is when 
the stomach becomes colonised by bacteria which can both reduce nitrate to nitrite 
and nitrite to nitrosating species and N-nitroso compounds.  This mechanism 
which occurs in the achlorhydric stomach is thought to be relevant in patients who 
develop non-cardia gastric cancer secondary to atrophic gastritis 94, 145.  
 We were able to investigate the effect of acidic gastro-oesophageal reflux 
on the location of the nitrosative chemistry. In order to do this, we studied patients 
with Barrett’s oesophagus as they usually have severe reflux disease.  In these 
subjects, we found that nitrite and N-nitrosomorpholine was detected in the 
oesophageal, as well as gastric, segments.  In addition, the extent to which the 
chemistry was detected in the oesophagus versus stomach was directly related to 
the amount of reflux occurring while the probe was in-situ.  From this correlation, 
it is apparent that during reflux 80% of the nitrosating chemistry was occurring 
within the oesophageal segments.  Normally, the nitrosative chemistry occurs due 
to the swallowed saliva encountering acid on entering the stomach and occurs 
predominantly within the proximal stomach. In contrast, during reflux, the 
chemistry occurs in the oesophagus due to the acid entering the oesophagus and 
reacting with the nitrite within the oesophageal lumen. The impaired oesophageal 
clearance characteristic of severe reflux disease is likely to contribute to the 
degree of nitrosative chemistry occurring within the oesophagus. 
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We were also able to study the ratio of nitrite to nitrosomorpholine occurring 
within the oesophageal segments versus the gastric segments.  The ratio of nitrite 
to N-nitrosomorpholine observed in the stomach of the reflux patients following 
nitrate was similar to that observed in the healthy volunteers following nitrate. 
However, the ratio in the oesophageal sections of the silastic tube was 
significantly lower than in the stomach, indicating that in the oesophagus a higher 
proportion of the luminal nitrite was in the form of nitrous acid and nitrosating 
species versus nitric oxide than in the stomach. A similar trend was observed in 
the proximal versus the distal stomach of the healthy volunteers following nitrate 
as discussed above. This indicates that, during acid reflux, nitrate induces 
nitrosative stress within the oesophagus by two distinct mechanisms. The first 
mechanism involves generation of high concentrations of luminal nitric oxide 
arising from reaction between salivary nitrite and acidic gastric juice containing 
ascorbic acid and this will be the sole mechanism when nitrite is present in excess 
of ascorbic acid. This nitric oxide can diffuse into the epithelial cells, exerting 
nitrosative stress. The second mechanism involves the generation of nitrosating 
species within the lumen due the acidification of nitrite. This mechanism occurs 
when luminal supplies of ascorbic acid have been exhausted. Both mechanisms of 
nitrosative stress are also apparent in the proximal stomach following nitrate.  
Currently available analytical methods do not allow the measurement of 
N-nitroso compounds within endoscopic epithelial biopsies and we therefore 
studied their generation using an in situ compartment of neutral pH containing the 
N-nitrosatable compound morpholine. Our current studies do not allow accurate 
prediction of the extent to which the luminal nitrosative chemistry is generating 
N-nitroso compounds within the actual epithelial cells. However, both of these 
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mechanisms of nitrosative stress could result in damage to oesophageal epithelial 
DNA in humans. Epithelial cells contain an abundant and wide range of 
compounds (secondary amines, polyamines, amino acids, peptides and amides) 
which can be N-nitrosated to mutagenic products129-134 and therefore provide 
potential substrates for nitric oxide-mediated N-nitrosation. Additionally, during 
reflux of gastro-duodenal contents into the oesophagus, the oesophageal lumen 
contains nitrosatable compounds such as bile acid conjugates, which are potential 
substrates for luminal, acid-mediated N-nitrosation to form N-nitrosamines such 
as N-nitrosoglycocholic acid129, 130.  In animal models, oesophageal epithelium 
subject to duodeno-oesophageal reflux is more susceptible to the mutagenic 
effects of luminal N-nitrosocompounds79, 146, 147. 
Our use of morpholine within the silastic tube provides a measure of nitric 
oxide-mediated nitrosative stress per se, and not just of its ability to form N-
nitroso compounds. Nitric oxide-induced nitrosative stress can also induce DNA 
damage by other mechanisms. These include directly de-aminating DNA and 
inactivating DNA repair enzymes such as O6-alkylguanine DNA alkyl 
transferase148-150 and DNA repair proteins such as formamidopyrimidine DNA-
glycosylase that repairs 8-oxodeoxyguanine residues146, 151, 152.  
A synergistic action may therefore occur during reflux of gastro-duodenal 
contents into the oesophagus. Erosion of the oesophageal epithelial surface by 
acidic reflux will make the basal stem cells more exposed to the luminal 
nitrosative chemistry. In addition, acid reflux stimulates basal cell proliferation 
and replicating DNA will therefore be more sensitive to the mutagenic effects of 
nitric oxide and of luminally and epithelially generated N-nitroso compounds, all 
produced by the same acid reflux153-156. 
 128
Further studies are required to determine if the nitrosative stress 
demonstrated in our in situ epithelial model translates into cellular damage and 
mutagenesis and identification of a suitable biomarker is needed. This could be 
investigated by looking for specific or non-specific markers of DNA damage in 
oesophageal and gastric epithelial cells following exposure to high luminal 
concentrations of nitric oxide. 
N-nitrosocompounds result in specific damage to the composition of DNA. 
In vitro studies have detected the presence of the N-nitroso compound specific 
adduct O(6)-carboxymethylguanine in human blood DNA following reaction of 
nitric oxide with glycine157. Further studies into the effect of diet on colon cancer 
have demonstrated that volunteers on a red meat diet had a significant increase in 
the endogenous formation of N-nitrosocompounds compared with vegetarians as 
measured by apparent total N-nitroso compound in faeces. This rise in colonic N-
nitroso compounds was associated with significantly higher numbers of exfoliated 
colonic cells staining positive for the DNA adduct O(6)-carboxymethyl 
guanine158.  
Non specific DNA damage following nitric oxide exposure could 
potentially be assessed using the comet assay, which measures strand breaks and 
alkali-labile sites in DNA. This assay has confirmed higher levels of DNA 
damage within Barrett’s mucosa than squamous oesophageal mucosa in Barrett’s 
oesophagus patients, with the highest levels of DNA damage being associated 
with increased risk of development of high grade dysplasia and malignancy159. It 
has also been used to highlight potentially mutagenic consequences of employing 
chromo-endoscopy with methylene blue in Barrett’s surveillance programmes160. 
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Further studies are also required to ascertain the stage at which N-
nitrosative stress may influence mutagenesis. In preliminary studies, malignant 
and pre-malignant oesophageal cell lines have been exposed to physiological 
levels of nitric oxide. Nitric oxide exposure increased the ability of cell lines 
containing adenocarcinoma or high grade dysplasia to invade through Matrigel, 
but did not affect the behaviour of non-dysplastic Barrett’s oesophagus cell lines. 
Nitric oxide induced invasive behaviour correlated with the induction of matrix 
metalloproteinases (MMPs) 1 and 9 and tissue inhibitor of MMP 1 (TIMP1), all of 
which have previously been implicated in invasion161. Maximum expression of 
genes for these proteins was observed 1-3 hours after the addition of nitric oxide. 
These findings indicate that nitric oxide may promote disease progression in the 
later stages of carcinogenesis by increasing invasive potential through the 
regulation of genes known to be involved in invasion. Although the cell lines were 
exposed to concentrations of nitric oxide similar to those found where saliva 
meets gastric acid, it is unclear if they were subjected to the same rapid rate of 
delivery as occurs physiologically and further investigations in this area are 
warranted. 
In summary, our studies indicate that nitric oxide generated by the reaction 
between salivary nitrite and acidic gastric juice may induce nitrosative stress and 
generation of N-nitroso compounds within adjacent compartments of neutral pH 
such as the epithelial cells.  Our studies also demonstrate that during acid reflux, 
this potentially mutagenic chemistry occurs predominantly or entirely within the 
lumen of the oesophagus.  This chemistry may be particularly harmful to patients 
with erosive esophagitis whose epithelium will be more sensitive to chemical 
mutagenesis. 
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